About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
696 genotypes with 840 annotations displayed of selected term and subterms
Searched Term: abnormal tumor pathology
Allelic Composition
(Genetic Background)		 Annotated Term Reference
A4gnttm1Jnaka/A4gnttm1Jnaka
(B6.129S6-A4gnttm1Jnaka) 		increased tumor growth/size J:184485
Acetm6Keb/Ace+
(involves: 129 * C57BL/6) 		decreased tumor growth/size J:122178
Acetm6Keb/Acetm6Keb
(involves: 129 * C57BL/6) 		abnormal tumor morphology J:122178
decreased tumor growth/size J:122178
Acetm6Keb/Acetm6Keb
(involves: 129 * C57BL/6 * CD-1) 		decreased tumor growth/size J:122178
Acot12em1Holi/Acot12em1Holi
(involves: C57BL/6J * C57BL/6N) 		increased tumor growth/size J:335836
Adam9tm1Bbl/Adam9tm1Bbl
(involves: 129) 		decreased tumor growth/size J:148993
Adam15tm1Bbl/Adam15tm1Bbl
(involves: 129X1/SvJ * C57BL/6J) 		decreased tumor growth/size J:217858
Adam15tm1Bbl/Adam15tm1Bbl
(B6.129X1-Adam15tm1Bbl) 		decreased tumor growth/size J:84800
Adam15tm2.1Bbl/Adam15tm2.1Bbl
(involves: 129 * 129P2/OlaHsd * C57BL/6J * SJL) 		decreased tumor growth/size J:217858
Adamts12tm1Agno/Adamts12tm1Agno
(Not Specified) 		abnormal tumor vascularization J:160778
increased tumor growth/size J:160778
Adap1tm1c(EUCOMM)Wtsi/Adap1tm1c(EUCOMM)Wtsi
Tg(tetO-HRAS)65Lc/0
(involves: C3H * C57BL/6N * FVB/N) 		decreased tumor growth/size J:284709
Adgrl4tm1Adbg/Adgrl4tm1Adbg
(involves: C57BL/6) 		abnormal tumor vascularization J:330927
Adipoqtm1Chan/Adipoq+
Tg(MMTV-PyVT)634Mul/0
(B6.Cg-Adipoqtm1Chan Tg(MMTV-PyVT)634Mul) 		abnormal tumor morphology J:147458
increased metastatic potential J:147458
increased tumor growth/size J:147458
Adipoqtm1Chan/Adipoq+
Tg(MMTV-PyVT)634Mul/0
(FVB.Cg-Adipoqtm1Chan Tg(MMTV-PyVT)634Mul) 		abnormal tumor morphology J:147458
increased metastatic potential J:147458
increased tumor growth/size J:147458
Aggf1Gt(PT036)Byg/Aggf1+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal tumor vascularization J:239252
Aggf1tm1Qkw/Aggf1+
(involves: 129 * C57BL/6) 		abnormal tumor vascularization J:239252
Amhr2tm3(cre)Bhr/Amhr2+
Ctnnb1tm1Mmt/Ctnnb1+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ) 		increased metastatic potential J:149060, J:142150
Amotl1tm1Laho/Amotl1tm1Laho
Tg(Cdh5-cre/ERT2)1Rha/0
(involves: C57BL/6) 		abnormal tumor vascularization J:253854
Amotl1tm1Laho/Amotl1tm1Laho
Tg(Cdh5-cre/ERT2)1Rha/0
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * FVB/N) 		abnormal tumor vascularization J:253854
Antxr1tm1.2Bstc/Antxr1tm1.2Bstc
(B6.Cg-Antxr1tm1.2Bstc) 		decreased tumor growth/size J:150947
Anxa1tm1Rjf/Anxa1tm1Rjf
(involves: 129 * C57BL/6) 		abnormal tumor vascularization J:153690
decreased metastatic potential J:153690
decreased tumor growth/size J:153690
Anxa1tm1Rjf/Anxa1tm1Rjf
Tg(MMTV-PyVT)634Mul/?
(involves: FVB/N) 		decreased metastatic potential J:174635
decreased tumor growth/size J:174635
ApcGt(XA018)Byg/Apc+
(B6.129P2-ApcGt(XA018)Byg) 		increased tumor growth/size J:202877
ApcGt(XA018)Byg/Apc+
((B6.129P2-ApcGt(XA018)Byg x C3H/HeJ)F1) 		decreased tumor growth/size J:202877
ApcMin/Apc+
(involves: C57BL/6J) 		abnormal tumor pathology J:268691
decreased tumor growth/size J:268691
ApcMin/Apc+
Arhgef4tm1Taki/Arhgef4+
(B6J.Cg-Arhgef4tm1Taki ApcMin) 		decreased tumor growth/size J:157023
ApcMin/Apc+
Arhgef4tm1Taki/Arhgef4tm1Taki
(B6J.Cg-Arhgef4tm1Taki ApcMin) 		decreased tumor growth/size J:157023
ApcMin/Apc+
Arhgef4tm1Taki/Arhgef4tm1Taki
Spata13tm1Taki/Spata13tm1Taki
(B6J.Cg-Arhgef4tm1Taki Spata13tm1Taki ApcMin) 		abnormal tumor pathology J:157023
abnormal tumor vascularization J:157023
decreased tumor growth/size J:157023
ApcMin/Apc+
Col1a1tm9(tetO-Dnmt3b_i1)Jae/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J) 		increased tumor growth/size J:127808
ApcMin/Apc+
Dclk1tm1.1(cre/ERT2)Seno/Dclk1+
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sortm1(HBEGF)Awai
(involves: 129S4/SvJaeSor * C57BL/6) 		abnormal tumor morphology J:193873
ApcMin/Apc+
Glp2rtm1Ddr/Glp2r+
(involves: C57BL/6J) 		abnormal tumor morphology J:141821
ApcMin/Apc+
Glp2rtm1Ddr/Glp2rtm1Ddr
(involves: C57BL/6J) 		abnormal tumor morphology J:141821
ApcMin/Apc+
Gt(ROSA)26Sortm2(Rnf187)Jhai/Gt(ROSA)26Sor+
Tg(Vil1-cre)20Syr/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased tumor growth/size J:173145
ApcMin/Apc+
Hltftm1.1Hdin/Hltftm1.1Hdin
(involves: 129 * C57BL/6 * FVB/N) 		increased metastatic potential J:252991
ApcMin/Apc+
Hsd11b2tm1.1Mzz/Hsd11b2tm1.1Mzz
Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6 * C57BL/6J) 		decreased tumor growth/size J:205456
ApcMin/Apc+
Il22ra2tm2Vlcg/Il22ra2tm2Vlcg
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac) 		increased tumor growth/size J:189217
ApcMin/Apc+
Mapkapk2tm1.1Gkl/Mapkapk2tm1.1Gkl
Tg(Tie1-cre)9Ref/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6J) 		decreased tumor growth/size J:262876
ApcMin/Apc+
Mapkapk2tm1.1Gkl/Mapkapk2tm1.1Gkl
Twist2tm1.1(cre)Dor/Twist2+
(involves: 129X1/SvJ * BALB/cJ * C57BL/6J) 		decreased tumor growth/size J:262876
ApcMin/Apc+
Mapkapk2tm1.2Gkl/Mapkapk2tm1.2Gkl
(involves: BALB/cJ * C57BL/6J) 		abnormal tumor vascularization J:262876
decreased tumor growth/size J:262876
ApcMin/Apc+
Mbd2tm1Bh/Mbd2tm1Bh
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		decreased tumor growth/size J:83087
ApcMin/Apc+
Mmp7tm1Lmm/Mmp7tm1Lmm
(involves: C57BL/6 * C57BL/6J) 		abnormal tumor morphology J:38609
ApcMin/Apc+
Nos2tm1Lau/Nos2+
(B6.Cg-Nos2tm1Lau ApcMin) 		decreased tumor growth/size J:73152
ApcMin/Apc+
Nos2tm1Lau/Nos2tm1Lau
(B6.Cg-Nos2tm1Lau ApcMin) 		decreased tumor growth/size J:73152
ApcMin/Apc+
Recql4tm1Glu/Recql4tm1Glu
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased tumor growth/size J:97101
ApcMin/Apc+
Spata13tm1Taki/Spata13+
(B6J.Cg-Spata13tm1Taki ApcMin) 		decreased tumor growth/size J:157023
ApcMin/Apc+
Spata13tm1Taki/Spata13tm1Taki
(B6J.Cg-Spata13tm1Taki ApcMin) 		decreased tumor growth/size J:157023
ApcMin/Apc+
Tg(Vil1-PPARGC1A)#Amos/0
(involves: C57BL/6J * FVB/N) 		decreased tumor growth/size J:171361
ApcMin/Apc+
Tmem9tm1d(EUCOMM)Wtsi/Tmem9tm1d(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N) 		abnormal tumor pathology J:268691
decreased tumor growth/size J:268691
ApcMin/Apc+
Zbtb33tm1.1Bird/Y
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		decreased tumor growth/size J:104155
Apctm1.1Alew/Apc+
(B6.129-Apctm1.1Alew) 		abnormal tumor morphology J:180275
Apctm1.1Tyj/Apc+
(involves: 129S4/SvJaeSor * C57BL/6) 		increased tumor growth/size J:160399
Apctm1Cip/Apc+
Cdhr5tm1Lex/Cdhr5tm1Lex
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6) 		increased tumor growth/size J:301471
Apctm1Cip/Apc+
Mki67em1Dfis/Mki67em1Dfis
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		decreased tumor growth/size J:304800
Apctm1Mmt/Apc+
Mmp7tm1Lmm/Mmp7tm1Lmm
Smad4tm1Mmt/Smad4+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ) 		decreased tumor growth/size J:142797
Apctm1Rak/Apc+
Dcctm1.1Mehl/Dcctm1.1Mehl
(involves: 129P2/OlaHsd * C57BL/6) 		increased metastatic potential J:181517
Apctm1Tno/Apc+
Il17ratm1Koll/Il17ratm1Koll
Tg(CDX2-cre)101Erf/0
(involves: 129 * 129S4/SvJae * C57BL/6J * SJL/J) 		decreased tumor growth/size J:189226
Apctm1Tno/Apc+
Il23atm1Ngh/Il23atm1Ngh
Tg(CDX2-cre)101Erf/0
(involves: 129 * 129S4/SvJae * C57BL/6J * SJL/J) 		decreased tumor growth/size J:189226
Apctm1Tno/Apc+
Il23rtm1.2Trin/Il23rtm1.2Trin
Tg(CDX2-cre)101Erf/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL/J) 		decreased tumor growth/size J:189226
Apctm1Tno/Apc+
Rac3tm1.1Bea/Rac3tm1.1Bea
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2) 		decreased tumor growth/size J:306088
Apctm1Tno/Apctm1Tno
Elp3tm1.1Tac/Elp3tm1.1Tac
Lgr5tm1(cre/ERT2)Cle/Lgr5+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac) 		decreased tumor growth/size J:227334
Apctm2.1Alew/Apc+
(B6.129-Apctm2.1Alew) 		abnormal tumor pathology J:180057
Apctm2Rak/Apc+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)6Tuv/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * FVB/N * SJL) 		increased metastatic potential J:234310
Apctm2Rfo/Apc+
((C57BL/6J x 129P2/OlaHsd)F1) 		increased metastatic potential J:204440
Apobec3Rfv3-r/Apobec3+
((B10.A x A)F1) 		abnormal tumor morphology J:6147
Artm1.1Chc/Y
(involves: 129S/SvEv * C57BL/6 * FVB/N) 		abnormal tumor morphology J:120844
Artm3.1(AR)Ska/Y
Tg(KLKB1-cre/ERT2)1Pcn/0
Tg(TRAMP)8247Ng/0
(involves: C57BL/6 * C57BL/6J * CBA) 		abnormal tumor morphology J:170092
increased tumor growth/size J:170092
Arhgef4tm1Taki/Arhgef4tm1Taki
(involves: C57BL/6 * C57BL/6J * CBA) 		abnormal tumor morphology J:159959
abnormal tumor vascularization J:159959
decreased tumor growth/size J:159959
Arid1atm1.1Mag/Arid1atm1.1Mag
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * CD-1) 		increased metastatic potential J:219794
Arl6ip5tm1.2Jwzh/Arl6ip5tm1.2Jwzh
(B6.129X1-Arl6ip5tm1.2Jwzh) 		decreased tumor growth/size J:187133
Armcx3tm1.1Eso/Y
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6) 		abnormal tumor morphology J:345411
Atf2Tg(Gzma-Klra1)7Wum/Atf2+
(involves: C57BL/6) 		increased metastatic potential J:61178
Atf3tm1.1Hai/Atf3tm1.1Hai
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * FVB/N) 		decreased metastatic potential J:201626
Atf3tm1Dron/Atf3tm1Dron
(involves: 129X1/SvJ * C57BL/6) 		decreased metastatic potential J:201626
Atf3tm1Dron/Atf3tm1Dron
Tg(MMTV-PyVT)634Mul/0
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		decreased metastatic potential J:201626
decreased tumor growth/size J:201626
Atg5em1Smoc/Atg5em1Smoc
S100a4em1(cre)Zhyg/S100a4+
(involves: C57BL/6J) 		abnormal tumor morphology J:330821
decreased tumor growth/size J:330821
Atp6v0a2tm1Kdb/Atp6v0a2tm1Kdb
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca) 		increased metastatic potential J:274048
B3gnt6tm1Lx/B3gnt6tm1Lx
(involves: 129S1/Sv * C57BL/6J) 		increased tumor growth/size J:123826
Bcl11btm1Peli/Bcl11btm1Peli
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6J) 		decreased metastatic potential J:161373
Bhlha15tm2(Kras)Skz/Bhlha15+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6) 		increased metastatic potential J:105076
Braftm1.1Brd/Braf+
Tg(Vil1-cre)997Gum/0
Trp53tm2Tyj/Trp53tm2Tyj
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6 * SJL) 		abnormal tumor pathology J:199307
increased metastatic potential J:199307
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1) 		increased metastatic potential J:170095
Braftm1Mmcm/Braf+
Ptentm1Rdp/Ptentm1Rdp
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased metastatic potential J:151023
Braftm1Mmcm/Braf+
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129P2/OlaHsd * 129S1/Sv * FVB) 		increased metastatic potential J:151023
Braftm1Mmcm/Braf+
Tg(TPO-cre/ERT2)1139Tyj/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac) 		increased metastatic potential J:208854
Braftm1Mmcm/Braftm1Mmcm
Nkx3-1tm4(cre/ERT2)Mms/Nkx3-1+
Ptentm1Hwu/Pten+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		increased metastatic potential J:191327
Brca1tm1Bhk/Brca1+
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
(C.129-Cdkn2ctm1Yxi Brca1tm1Bhk) 		increased metastatic potential J:198018
Brca1tm1Brn/Brca1tm1.1Jjon
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		abnormal tumor morphology J:178595
abnormal tumor pathology J:178595
Brca1tm1Brn/Brca1tm1Brn
Tg(Krt18-EGFP,-TAg121)36Ysng/0
Trp53tm1Brn/Trp53tm2Tyj
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N) 		increased metastatic potential J:189304
Brca1tm1Brn/Brca1tm1Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		abnormal tumor morphology J:178595
abnormal tumor pathology J:178595
Brca1tm2Cxd/Brca1tm2Cxd
Pkmtm1.1Mgvh/Pkmtm1.1Mgvh
Trp53tm1Brd/Trp53+
Tg(MMTV-cre)4Mam/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N) 		increased metastatic potential J:205213
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Tyj/Trp53+
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL) 		abnormal tumor morphology J:144617
Bub1btm1.1Jvd/Bub1b+
(involves: 129S6/SvEvTac * C57BL/6) 		increased tumor growth/size J:293084
Bub1btm1Jvd/Bub1btm3.1Jvd
(involves: 129S6/SvEvTac * C57BL/6) 		increased tumor growth/size J:293084
Bub1btm2.1Jvd/Bub1b+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		increased tumor growth/size J:194926
Bub1btm3.1Jvd/Bub1b+
(involves: 129S6/SvEvTac * C57BL/6) 		increased tumor growth/size J:293084
Calcatm1.1(cre/ERT2)Ptch/Calca+
Trp53tm1Brn/Trp53tm1Brn
Rb1tm2Brn/Rb1tm2Brn
Ptentm1Hwu/Ptentm1Hwu
(involves: 129 * 129P2/OlaHsd * 129S4/SvJae * BALB/c * FVB/N) 		increased metastatic potential J:190366
Casp1tm1Flv/Casp1tm1Flv
Casp4del/Casp4del
(involves: 129S2/SvPas) 		decreased metastatic potential J:59893
decreased tumor growth/size J:59893
Cav2tm1(KOMP)Mbp/Cav2tm1(KOMP)Mbp
(C57BL/6N-Cav2tm1(KOMP)Mbp) 		abnormal tumor morphology J:217189
abnormal tumor pathology J:217189
abnormal tumor vascularization J:217189
decreased tumor growth/size J:217189
tumor regression J:217189
Ccdc25em1Smoc/Ccdc25em1Smoc
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6NTac * FVB/N) 		decreased metastatic potential J:291299
Ccdc80tm1Ppal/Ccdc80tm1Ppal
(Not Specified) 		increased metastatic potential J:217742
Ccm2ltm1Mlkn/Ccm2ltm1Mlkn
(involves: 129 * C57BL/6) 		abnormal tumor vascularization J:187714
decreased metastatic potential J:187714
decreased tumor growth/size J:187714
Ccn6tm1.1Cgkl/Ccn6tm1.1Cgkl
Tg(MMTV-cre)1Mam/0
(FVB/N-Ccn6tm1.1Cgkl Tg(MMTV-cre)1Mam) 		increased metastatic potential J:241259
Ccn6tm1.1Cgkl/Ccn6tm1.1Cgkl
Tg(MMTV-cre)1Mam/0
Tg(MMTV-PyVT)634Mul/0
(FVB/N-Ccn6tm1.1Cgkl Tg(MMTV-cre)1Mam Tg(MMTV-PyVT)634Mul) 		increased metastatic potential J:241259
Ccnd1tm1Wbg/Ccnd1tm5.1Pisc
Tg(CAG-cre/Esr1*)5Amc/0
Tg(MMTV-Erbb2)NK1Mul/0
(involves: 129S2/SvPas * C57BL/6 * CBA * FVB/N) 		decreased tumor growth/size J:192032
Ccr2tm1Ifc/Ccr2tm1Ifc
(B6.129S4-Ccr2tm1Ifc/J) 		decreased tumor growth/size J:122119
Ccr5tm1Kuz/Ccr5tm1Kuz
Tg(CAG-EGFP)1Osb/?
(involves: 129P2/OlaHsd * C3H * C57BL/6) 		decreased metastatic potential J:97833
Cd1tm1Gru/Cd1tm1Gru
(involves: 129S2/SvPas * BALB/c) 		decreased metastatic potential J:118828
Cd9tm1c(EUCOMM)Hmgu/Cd9+
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129X1/SvJ * C57BL/6N * FVB/N) 		decreased tumor growth/size J:280854
Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6) 		decreased tumor growth/size J:110162
Cd44tm1Mak/Cd44tm1Mak
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased metastatic potential J:100774
Cd44tm1Mak/Cd44tm1Mak
Tg(MMTV-PyVT)634Mul/0
(B6.Cg-Cd44tm1Mak Tg(MMTV-PyVT)634Mul) 		increased metastatic potential J:100774
Cd44tm1Mak/Cd44tm1Mak
Trp53tm1Tyj/Trp53+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * C57BL/6J) 		decreased metastatic potential J:76201
Cd82tm1.1Xaz/Cd82tm1.1Xaz
(B6NCr.Cg-Cd82tm1.1Xaz) 		abnormal tumor vascularization J:234155
Cd96tm1.1Mjs/Cd96tm1.1Mjs
(B6.129P2(Cg)-Cd96tm1.1Mjs) 		decreased metastatic potential J:209990
Cd151tm2Nki/Cd151tm2Nki
Itga3tm1Son/Itga3+
Krt14tm1(cre)Wbm/?
(FVB.129P2-Cd151tm2Nki Itga3tm1Son Krt14tm1(cre)Wbm) 		decreased tumor growth/size J:205736
Cd151tm2Nki/Cd151tm2Nki
Krt14tm1(cre)Wbm/?
(FVB.129P2-Cd151tm2Nki Krt14tm1(cre)Wbm) 		decreased tumor growth/size J:205736
Cd160tm1Yxf/Cd160tm1Yxf
(C57BL/6-Cd160tm1Yxf) 		increased tumor growth/size J:222131
Cd160tm1Yxf/Cd160tm1Yxf
Rag1tm1Mom/Rag1tm1Mom
(B6.Cg-Rag1tm1Mom Cd160tm1Yxf) 		increased tumor growth/size J:222131
Cd226tm1.1Cln/Cd226tm1.1Cln
(B6.129P2-Cd226tm1.1Cln) 		increased metastatic potential J:159749
increased tumor growth/size J:159749
Cd248tm1Huso/Cd248tm1Huso
(involves: 129S/SvEv * C57BL/6) 		decreased tumor growth/size J:107172
Cdatm1d(EUCOMM)Wtsi/Cdatm1d(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6J * C57BL/6N) 		decreased tumor growth/size J:332259
Cdc20tm1.1Mama/Cdc20tm1.2Mama
Polr2atm1(cre/ERT2)Bbd/Polr2a+
(involves: 129/Sv * BALB/cJ * C57BL/6 * CD-1 * SJL) 		decreased tumor growth/size J:167609
tumor regression J:167609
Cdcp1tm1.2Moas/Cdcp1tm1.2Moas
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sor+
Tg(KRT14-cre/ERT)20Efu/0
(involves: 129X1/SvJ * C57BL/6 * CD-1 * FVB/N * SJL) 		increased tumor growth/size J:194368
Cdcp1tm1.2Moas/Cdcp1tm1.2Moas
Tg(MMTV-PyVT)634Mul/0
(involves: 129 * C57BL/6 * FVB/N * SJL) 		increased tumor growth/size J:194368
Cdh1tm1Jjon/Cdh1tm1Jjon
Trp53tm1Brn/Trp53+
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		abnormal tumor vascularization J:116152
increased metastatic potential J:116152
Cdh1tm1Jjon/Cdh1tm1Jjon
Trp53tm1Brn/Trp53+
Tg(Wap-cre)51Nki/0
(involves: 129P2/OlaHsd * FVB/N) 		increased metastatic potential J:171765
Cdh1tm1Jjon/Cdh1tm1Jjon
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		abnormal tumor vascularization J:116152
increased metastatic potential J:116152
Cdh1tm1Jjon/Cdh1tm1Jjon
Trp53tm1Brn/Trp53tm1Brn
Tg(Wap-cre)51Nki/0
(involves: 129P2/OlaHsd * FVB/N) 		increased metastatic potential J:171765
Cdh1tm2Kem/Cdh1+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)7Mul/0
(involves: 129 * C57BL/6 * FVB/N) 		increased metastatic potential J:212549
Cdh1tm2Kem/Cdh1+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)6Tuv/0
(involves: 129 * C57BL/6 * FVB/N) 		increased metastatic potential J:212549
Cdh13tm1Brns/Cdh13tm1Brns
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * FVB/N) 		abnormal tumor morphology J:132759
abnormal tumor vascularization J:132759
decreased tumor growth/size J:132759
increased metastatic potential J:132759
Cdk1tm2.1Kald/Cdk1tm2.1Kald
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6 * CBA * SJL) 		decreased tumor growth/size J:182141
Cdk4+/Cdk4+
Tg(Mt1-Hgf)#Lmb/0
(B6.Cg-Cdk4tm1.1Bbd Tg(Mt1-Hgf)#Lmb) 		increased metastatic potential J:111992
Cdk4tm1.1Bbd/Cdk4+
Tg(Mt1-Hgf)#Lmb/0
(B6.Cg-Cdk4tm1.1Bbd Tg(Mt1-Hgf)#Lmb) 		decreased tumor growth/size J:111992
increased metastatic potential J:111992
Cdk4tm1.1Bbd/Cdk4tm1.1Bbd
Krt14tm1(cre)Wbm/Krt14+
Pard3tm1Shoh/Pard3tm1Shoh
Tg(Mt1-Hgf)#Lmb/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J) 		increased metastatic potential J:240961
increased tumor growth/size J:240961
Cdk4tm1.1Bbd/Cdk4tm1.1Bbd
Tg(Mt1-Hgf)#Lmb/0
(B6.Cg-Cdk4tm1.1Bbd Tg(Mt1-Hgf)#Lmb) 		increased metastatic potential J:111992
increased tumor growth/size J:111992
Cdk4tm2.1Bbd/Cdk4tm2.1Bbd
Krastm1Bbd/Krastm2Bbd
Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ) 		decreased tumor growth/size J:161780
Cdk4tm2.2Bbd/Cdk4tm2.1Bbd
Krastm1Bbd/Krastm2Bbd
Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ) 		decreased tumor growth/size J:161780
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S1/SvImJ * 129S2/SvPas * C57BL/6J) 		increased metastatic potential J:83967
Cdkn1btm1Jro/Cdkn1btm1Jro
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * CD-1 * FVB/N) 		abnormal tumor pathology J:318035
decreased tumor growth/size J:318035
Cdkn1btm1Mlf/Cdkn1btm1Mlf
Tg(MMTV-vHaras)SH1Led/0
(involves: 129S4/SvJaeSor * C57BL/6J * CD-1) 		increased tumor growth/size J:80271
Cdkn2atm1.1Brn/Cdkn2a+
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		increased metastatic potential J:132943
Cdkn2atm1.1Brn/Cdkn2atm1.1Brn
Nf2tm2Gth/Nf2tm2Gth
(involves: 129P2/OlaHsd * FVB/N) 		osseous metaplasia J:131179
Cdkn2atm1Cjs/Cdkn2atm1Cjs
(involves: 129X1/SvJ * C57BL/6 * NIH/OlaHsd) 		increased metastatic potential J:93298
increased tumor growth/size J:93298
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6 * NIH/OlaHsd) 		increased tumor growth/size J:93298
Cdkn2atm1Rdp/Cdkn2a+
Tg(CAG-Bgeo,-tTA,-EGFP)2A11Kuw/0
Tg(Pdx1-cre)6Tuv/0
Tg(tetO-MYC)36Bop/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * FVB/N * SJL) 		increased metastatic potential J:197052
Cdkn2atm1Rdp/Cdkn2atm1Rdp
X/Tg(Tyr-HRAS)60Lc
(involves: 129/Sv * C57BL/6J * CBA/J * SJL) 		decreased tumor growth/size J:164588
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Tg(Tyr-NRAS*Q61K)1Bee/?
(involves: 129/Sv * C57BL/6 * DBA/2 * SJL) 		increased metastatic potential J:98545
Cdkn2atm2.1Brn/Cdkn2atm2.1Brn
(involves: 129P2/OlaHsd * FVB/N) 		increased metastatic potential J:71393
Cdkn2atm2.1Nesh/Cdkn2atm2.1Nesh
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB) 		increased tumor growth/size J:164588
Cdkn2atm2.1Nesh/Cdkn2atm2.1Nesh
Nrastm1.1Nesh/Nrastm1.1Nesh
Stk11tm1.1Rdp/Stk11tm1.1Rdp
Tg(Tyr-cre/ERT2)13Bos/0
(B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nrastm1.1Nesh Cdkn2atm2.1Nesh Stk11tm1.1Rdp) 		increased metastatic potential J:220627
Cdkn2atm2.1Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased metastatic potential J:108298
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased metastatic potential J:124682
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased metastatic potential J:108298
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased metastatic potential J:108298
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased metastatic potential J:108298
Cdkn2atm4Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N) 		increased metastatic potential J:108298
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N) 		increased metastatic potential J:108298, J:87196
Cebpatm1Gonz/Cebpatm1Gonz
Tg(KRT5-cre)5132Jlj/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2J) 		increased tumor growth/size J:123139
Cebpbtm1Pfj/Cebpbtm1Pfj
Tg(Hba-x-v-Ha-ras)TG.ACLed/0
(involves: C57BL/6) 		decreased tumor growth/size J:73558
Chek1tm2.1Sje/Chek1+
Trp53tm1Brn/Trp53+
Tg(MMTV-cre)#Mam/0
(involves: 129P2/OlaHsd * FVB) 		abnormal tumor morphology J:162126
abnormal tumor vascularization J:162126
Chek1tm2.1Sje/Chek1tm2.1Sje
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)#Mam/0
(involves: 129P2/OlaHsd * FVB) 		abnormal tumor morphology J:162126
Cks1btm1Sir/Cks1btm1Sir
Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL) 		decreased metastatic potential J:121564
Col1a1tm1(tetO-EML4/ALK)Kkw/Col1a1+
Tg(Scgb1a1-rtTA)1Jaw/0
(involves: 129 * C57BL/6) 		abnormal tumor pathology J:166724
Col1a1tm1(tetO-EWSR1/ATF1)Yasu/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		tumor regression J:194505
Col1a1tm1(tetO-URI1)Ndj/Col1a1+
Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd) 		increased metastatic potential J:217463
Cpt1cGt(XL823)Byg/Cpt1c+
Nf1tm1Tyj/Nf1+
Trp53tm1Tyj/Trp53+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		decreased metastatic potential J:228258
Cst3tm1Karl/Cst3tm1Karl
(involves: 129S/SvEv * C57BL/6) 		increased metastatic potential J:62407
Ctsbtm1Jde/Ctsbtm1Jde
Ctsztm1Thre/Ctsztm1Thre
Tg(MMTV-PyVT)634Mul/0
(FVB.129P2-Ctsztm1Thre Ctsbtm1Jde Tg(MMTV-PyVT)634Mul) 		abnormal tumor morphology J:157541
decreased metastatic potential J:157541
decreased tumor growth/size J:157541
Ctsbtm1Jde/Ctsbtm1Jde
Tg(MMTV-PyVT)634Mul/0
(FVB.129P2-Ctsbtm1Jde Tg(MMTV-PyVT)634Mul) 		abnormal tumor morphology J:157541
decreased metastatic potential J:157541
decreased tumor growth/size J:157541
Ctsztm1Thre/Ctsztm1Thre
Tg(MMTV-PyVT)634Mul/0
(FVB.129P2-Ctsztm1Thre Tg(MMTV-PyVT)634Mul) 		decreased metastatic potential J:157541
increased tumor growth/size J:157541
Cul9tm1.2Yxi/Cul9+
Tg(IghMyc)22Bri/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6 * FVB/N * SJL) 		abnormal tumor pathology J:170976
Cul9tm1.2Yxi/Cul9tm1.2Yxi
Tg(IghMyc)22Bri/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6 * FVB/N * SJL) 		abnormal tumor pathology J:170976
Cxcl16tm1Syon/Cxcl16tm1Syon
(B6.129P2-Cxcl16tm1Syon) 		increased tumor growth/size J:155199
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(B6.Cg-Il8rbtm1Mwm) 		abnormal tumor morphology J:88233
decreased metastatic potential J:88233
decreased tumor growth/size J:88233
Cxcr2tm1Mwm/Cxcr2tm1Mwm
Tg(TRAMP)8247Ng/?
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		decreased tumor growth/size J:115957
Cxcr3tm1Wwh/Y
Tg(TRAMP)8247Ng/?
(involves: C57BL/6) 		increased tumor growth/size J:115957
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din) 		decreased metastatic potential J:110181
decreased tumor growth/size J:110181
Cygbtm1Nka/Cygb+
(B6.Cg-Cygbtm1Nka) 		increased tumor growth/size J:174134
Cygbtm1Nka/Cygbtm1Nka
(B6.Cg-Cygbtm1Nka) 		abnormal tumor pathology J:174134
increased tumor growth/size J:174134
Dcctm1Nki/Dcctm1Nki
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/?
(involves: 129P2/OlaHsd * FVB/N) 		increased metastatic potential J:181090
Ddr2tm1a(EUCOMM)Wtsi/Ddr2tm1a(EUCOMM)Wtsi
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6N * FVB/N) 		decreased metastatic potential J:236031
Ddr2tm1b(EUCOMM)Wtsi/Ddr2tm1b(EUCOMM)Wtsi
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6N * FVB/N) 		decreased metastatic potential J:236031
Ddr2tm1c(EUCOMM)Wtsi/Ddr2tm1c(EUCOMM)Wtsi
Tg(KRT14-cre)1Amc/0
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * C57BL/6N * CBA * FVB/N) 		decreased metastatic potential J:236031
Dicer1tm1Tara/Dicer1tm1Tara
Ptentm1Hwu/Ptentm1Hwu
Amhr2tm3(cre)Bhr/Amhr2+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd) 		increased metastatic potential J:182161
Dicer1tm1Tara/Dicer1tm1Tara
Ptentm1Hwu/Ptentm1Hwu
Trp53tm2Tyj/Trp53+
Amhr2tm3(cre)Bhr/Amhr2+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd) 		increased metastatic potential J:222579
Dlg2tm1a(EUCOMM)Wtsi/Dlg2tm1a(EUCOMM)Wtsi
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(Col1a1-cre)1Kry/0
(involves: 129 * 129P2/OlaHsd * C57BL/6N * FVB/N) 		increased tumor growth/size J:269943
Dmq3M16i/?
(involves: FVB/NJ * M16i) 		increased metastatic potential J:136011
Dmq4FVB/NJ/?
(involves: FVB/NJ * M16i) 		increased metastatic potential J:136011
Dmtf1tm1Cjs/Dmtf1+
Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6) 		abnormal metastatic potential J:126002
Dmtf1tm1Cjs/Dmtf1+
Krastm3Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6) 		abnormal metastatic potential J:126002
Dmtf1tm1Cjs/Dmtf1tm1Cjs
Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6) 		abnormal metastatic potential J:126002
Dnajc27Gt(OST374030)Lex/Dnajc27Gt(OST374030)Lex
(involves: 129S5/SvEvBrd * C57BL/6N) 		decreased tumor growth/size J:210622
Dock1tm2.1Jfco/Dock1tm2.1Jfco
Tg(MMTV-Erbb2*,-cre)1Mul/0
(involves: C57BL/6 * FVB/NJ) 		decreased metastatic potential J:196659
decreased tumor growth/size J:196659
Dock4tm1(NCOM)Mfgc/Dock4+
(involves: C57BL/6J * C57BL/6NCrl) 		abnormal tumor vascularization J:224385
Dot1ltm1.1Saam/Dot1ltm1.1Saam
(involves: 129S1/Sv * C57BL/6) 		decreased tumor growth/size J:193161
E2f1tm1Njd/E2f1tm1Njd
(involves: 129S2/SvPas * C57BL/6) 		increased metastatic potential J:33099
Ednrbtm1Ywa/Ednrb+
Tg(Mt1-RET)304Ina/0
(involves: 129S7/SvEvBrd * BALB/c * C57BL/6) 		increased metastatic potential J:155735
Egfrwa2/Egfr+
Fostm2(Fosl1)Wag/Fostm2(Fosl1)Wag
Tg(KRT5-SOS1)892A6Wag/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased tumor growth/size J:175064
Egfrwa2/Egfr+
Fostm3.1Wag/Fostm3.1Wag
Tg(KRT5-SOS1)892A6Wag/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL) 		decreased tumor growth/size J:175064
Egfrwa2/Egfr+
Fostm5.1Wag/Fostm5.1Wag
Tg(KRT5-SOS1)892A6Wag/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL) 		decreased tumor growth/size J:175064
Egfrwa2/Egfr+
Fostm6.1Wag/Fostm6.1Wag
Tg(KRT5-SOS1)892A6Wag/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL) 		increased tumor growth/size J:175064
Egfrwa2/Egfr+
Rps6ka3tm1.1Kry/Y
Tg(KRT5-SOS1)892A6Wag/0
(involves: 129X1/SvJ * C57BL/6 * CBA) 		decreased tumor growth/size J:175064
Eif4eGt(RRO036)Byg/Eif4e+
Krastm3Tyj/Kras+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB/N) 		decreased tumor growth/size J:224214
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon
Lyz2tm1(cre)Ifo/Lyz2+
(B6.129P2-Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo) 		increased tumor growth/size J:184388
Emv72a/Emv72a
(involves: BALB/cAnNCr * C57BL/6NCr) 		increased tumor growth/size J:194735
Emv72b/Emv72b
(CAnNCr.B6NCr-Emv72b) 		decreased tumor growth/size J:194735
Epha2Gt(KST085)Byg/Epha2Gt(KST085)Byg
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased metastatic potential J:112120
Epha2tm1Jrui/Epha2tm1Jrui
Krastm4Tyj/Kras+
Trp53tm2.1Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * 129S4/SvJae * FVB/N) 		decreased metastatic potential J:244261
Epn1tm1.1Wami/Epn1tm1.1Wami
Epn2tm1Ocr/Epn2tm1Ocr
Tg(Cdh5-cre)7Mlia/0
(involves: C57BL/6J * FVB/N) 		decreased tumor growth/size J:193966
Epn1tm1.1Wami/Epn1tm1.1Wami
Epn2tm1Ocr/Epn2tm1Ocr
Tg(Cdh5-cre/ERT2)CIVE23Mlia/0
(involves: 129X1/SvJ * C57BL/6J) 		abnormal tumor vascularization J:193966
decreased tumor growth/size J:193966
Epn1tm1.1Wami/Epn1tm1.1Wami
Epn2tm1Ocr/Epn2tm1Ocr
Tg(Cdh5-cre/ERT2)CIVE23Mlia/0
Tg(TRAMP)8247Ng/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J) 		decreased tumor growth/size J:193966
Erbb2tm8(Erbb2)Mul/Erbb2+
Ptentm1Hwu/Pten+
Tg(MMTV-cre)7Mul/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N) 		increased metastatic potential J:133305
Erbb3tm1.1(ERBB3)Mul/Erbb3tm1.1(ERBB3)Mul
Tg(MMTV-Erbb2*)NDL2-5Mul/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		decreased metastatic potential J:189292
Errfi1tm1Jwj/Errfi1tm1Jwj
Pgrtm2(cre)Lyd/Pgr+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased metastatic potential J:162027
Esm1tm1.1Rha/Esm1tm1.1Rha
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * C57BL/6NTac) 		abnormal tumor vascularization J:246778
Espl1Gt(XL058)Byg/Espl1+
Trp53tm1Tyj/Trp53tm1Tyj
(B6.129-Trp53tm1Tyj Espl1Gt(XL058)Byg) 		abnormal tumor pathology J:174926
increased metastatic potential J:174926
Ets2tm1Rgo/Ets2+
Tg(MMTV-PyVT)634Mul/0
(involves: 129S2/SvPas * Black Swiss * FVB/N) 		decreased tumor growth/size J:57272
Ets2tm1Rgo/Ets2tm5.1Rgo
Ptentm1.1Mwst/Ptentm1.1Mwst
Tg(S100a4-cre)1Gle/0
(involves: 129S2/SvPas * FVB/N) 		abnormal tumor morphology J:153747
Ets2tm2Rgo/Ets2tm2Rgo
(involves: FVB/N) 		decreased tumor growth/size J:86530
Etv4tm1Hass/Etv4tm1Hass
Tg(MMTVneu)202Mul/Tg(MMTVneu)202Mul
(involves: FVB/N) 		decreased metastatic potential J:87017
F2rl1tm1Bpd/F2rl1tm1Bpd
Tg(MMTV-PyVT)634Mul/0
(B6.Cg-F2rl1tm1Bpd Tg(MMTV-PyVT)634Mul) 		abnormal tumor vascularization J:138924
Fasldel1Hong/Fasldel1Hong
(either: (involves: 129 * BALB/c * C57BL/6) or (involves: 129X1/SvJ * C3H/HeJ * C57BL/6)) 		increased metastatic potential J:112563
Fbln5tm1.1Hiya/Fbln5tm1.1Hiya
(involves: 129S6/SvEvTac) 		decreased tumor growth/size J:159246
Fbln5tm1Eno/Fbln5tm1Eno
(involves: 129S6/SvEvTac * C57BL/6) 		decreased metastatic potential J:159246
decreased tumor growth/size J:159246
Fbxw7as1tm1Opaz/Fbxw7as1tm1Opaz
(B6.Cg-Fbxw7as1tm1Opaz) 		decreased tumor growth/size J:103174
Fgfr4tm1Axul/Fgfr4+
Tg(WapTgfa)215Bri/0
(B6.Cg-Fgfr4tm1Axul Tg(WapTgfa)215Bri) 		increased metastatic potential J:156750
Fgfr4tm1Axul/Fgfr4tm1Axul
Tg(WapTgfa)215Bri/0
(B6.Cg-Fgfr4tm1Axul Tg(WapTgfa)215Bri) 		increased metastatic potential J:156750
Fgl1tm1b(EUCOMM)Hmgu/Fgl1tm1b(EUCOMM)Hmgu
(involves: BALB/cJ * C57BL/6N) 		decreased tumor growth/size J:269578
Fkbpltm1(KOMP)Wtsi/Fkbpl+
(involves: C57BL/6N) 		abnormal tumor vascularization J:226964
increased tumor growth/size J:226964
Fkbpltm1.1(KOMP)Wtsi/Fkbpl+
(involves: C57BL/6N * C57BL/6NTac) 		abnormal tumor vascularization J:226964
increased tumor growth/size J:226964
Flot2tm1Mak/Flot2tm1Mak
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		decreased metastatic potential J:203238
Fntbtm1.1Mbrg/Fntbtm1.2Mbrg
Krastm4Tyj/Kras+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/cJ * C57BL/6 * FVB/N) 		decreased tumor growth/size J:158937
Fntbtm1.1Mbrg/Fntbtm1.2Mbrg
Krastm4Tyj/Kras+
Pggt1btm1Mbrg/Pggt1btm1.1Mbrg
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/cJ * C57BL/6 * FVB/N) 		decreased tumor growth/size J:158937
Fntbtm1.1Mbrg/Fntbtm1.2Mbrg
Krastm4Tyj/Kras+
Pggt1btm1Mbrg/Pggt1btm1.1Mbrg
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/cJ * C57BL/6 * FVB/N) 		decreased tumor growth/size J:158937
Fostm1Pa/Fostm1Pa
(involves: 129X1/SvJ * C57BL/6J) 		abnormal tumor morphology J:78834
decreased metastatic potential J:78834
Fostm7Wag/Fostm7Wag
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased tumor growth/size J:190150
Foxn1nu/Foxn1nu
Gpc1tm1.1Alan/Gpc1tm1.1Alan
(involves: CD-1) 		decreased metastatic potential J:130809
Fut7tm1Jbl/Fut7tm1Jbl
(B6.129S2-Fut7tm1Jbl) 		decreased metastatic potential J:106671
Fzr1tm1.1Mama/Fzr1+
(involves: BALB/cJ * C57BL/6 * SJL) 		decreased tumor growth/size J:137456
Gadd45atm1Ajf/Gadd45atm1Ajf
Xpctm1Ecf/Xpctm1Ecf
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129X1/SvJ * C57BL/6)) 		increased metastatic potential J:101421
Gins4tm1Ntak/Gins4+
Tg(Krt19-Ptgs2,Krt19-Ptges)8Tko/0
Tg(Krt19-Wnt1)2Maos/0
(involves: 129P2/OlaHsd * C3H * C57BL/6) 		decreased tumor growth/size J:209708
Gpnmbtm1Ari/Gpnmbtm1Ari
(C57BL/6-Gpnmbtm1Ari) 		decreased tumor growth/size J:215931
Gpr4tm1Mglg/Gpr4tm1Mglg
(either: BALB/c-Gpr4tm1Mglg or B6.C-Gpr4tm1Mglg) 		abnormal tumor vascularization J:232324
decreased tumor growth/size J:232324
Gpr68tm1.1Yaxu/Gpr68tm1.1Yaxu
(B6.Cg-Gpr68tm1.1Yaxu) 		decreased tumor growth/size J:149315
Gpr68tm1.1Yaxu/Gpr68tm1.1Yaxu
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		decreased tumor growth/size J:149315
Gpr68tm1Yaxu/Gpr68tm1Yaxu
(involves: C57BL/6) 		increased tumor growth/size J:149315
Gt(ROSA)26Sortm1(CAG-Mir182)Dgk/Gt(ROSA)26Sortm1(CAG-Mir182)Dgk
Krastm4Tyj/Krastm4Tyj
Trp53tm1Brn/Trp53tm1Brn
(involves: 129/Sv * 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased metastatic potential J:217635
Gt(ROSA)26Sortm1(CAG-MYCN,-luc)Jhsc/Gt(ROSA)26Sor+
Ptentm2.1Ppp/Ptentm2.1Ppp
Rb1tm2Brn/Rb1tm2Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129 * 129S1/Sv * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased metastatic potential J:307910
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/?
Trp53tm5Tyj/Trp53tm5Tyj
(involves: 129S4/SvJae * C57BL/6) 		tumor regression J:118233
Gt(ROSA)26Sortm1(GNAQ*)Cvrk/Gt(ROSA)26Sor+
Tg(Mitf-cre)7114Gsb/0
(C3FeJ.Cg-Gt(ROSA)26Sortm1(GNAQ*)Cvkr Tg(Mitf-cre)7114Gsb/Cvrk) 		increased metastatic potential J:225597
Gt(ROSA)26Sortm1(Ntn4)Dyl/Gt(ROSA)26Sor+
Tg(KRT14-cre)1Amc/0
(involves: 129/Sv * C57BL/6 * CBA) 		abnormal tumor vascularization J:162807
increased metastatic potential J:162807
Gt(ROSA)26Sortm1(RAC1*)Jkis/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
(involves: 129S4/SvJae) 		increased tumor growth/size J:187582
Gt(ROSA)26Sortm1(RICTOR)Jger/Gt(ROSA)26Sortm1(RICTOR)Jger
Tg(GFAP-cre)25Mes/0
(involves: 129 * FVB/N) 		abnormal tumor vascularization J:192206
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sor+
Hk2tm1.1Uku/Hk2tm1.1Uku
Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * FVB/N) 		abnormal tumor vascularization J:210113
decreased tumor growth/size J:210113
Gt(ROSA)26Sortm1(tTA,tetO-Mir21)Fjsl/Gt(ROSA)26Sor+
Tg(Nes-cre)1Wmz/0
(involves: C57BL/6 * C57BL/6J * SJL/J) 		abnormal tumor morphology J:163919
Gt(ROSA)26Sortm1(tTA,tetO-Mir155)Fjsl/Gt(ROSA)26Sor+
Tg(Nes-cre)1Wmz/0
(involves: 129 * C57BL/6 * FVB/N * SJL/J) 		tumor regression J:185598
Gt(ROSA)26Sortm1.1(Loxl2)Acan/Gt(ROSA)26Sortm1.1(Loxl2)Acan
(Not Specified) 		abnormal tumor pathology J:220689
Gt(ROSA)26Sortm2Thl/Gt(ROSA)26Sor+
Ptentm1Hwu/Ptentm1Hwu
Trp53tm1Thl/Trp53tm1Thl
Tyrc-Brd/Tyrc-Brd
(involves: 129/Sv * 129S4/SvJae * C57BL/6) 		increased tumor growth/size J:172585
Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc/Gt(ROSA)26Sor+
(involves: C57BL/6) 		abnormal tumor morphology J:194308
increased tumor growth/size J:194308
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Hmga2tm1.1Mmw/Hmga2+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm2Tyj/Trp53+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * FVB/N) 		increased metastatic potential J:245611
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm2Tyj/Trp53+
(involves: 129 * C57BL/6NCrl * FVB/N) 		increased metastatic potential J:245611
Gzmatm1Ley/Gzmatm1Ley
(involves: 129X1/SvJ) 		increased tumor growth/size J:126114
Gzmbtm1Ley/Gzmbtm1Ley
(involves: 129X1/SvJ) 		decreased tumor growth/size J:126114
H2d/H2d
Trap1atm1.1Jvde/Y
(involves: 129 * BALB/cJ * C57BL/10 * DBA/2) 		tumor regression J:180807
H2axtm1Nus/H2axtm1Nus
(Not Specified) 		abnormal tumor vascularization J:149487
decreased tumor growth/size J:149487
H2axtm1Nus/H2axtm2.1Fwa
Tg(Cdh5-cre)7Mlia/0
(involves: 129S6/SvEvTac * FVB/N) 		abnormal tumor vascularization J:149487
decreased tumor growth/size J:149487
H19tm1Lda/H19tm1Lda
(involves: 129S2/SvPas * C57BL/6 * CBA) 		increased tumor growth/size J:138826
Hcsttm1.1Dnax/Hcsttm1.1Dnax
(involves: C57BL/6) 		decreased metastatic potential J:148086
decreased tumor growth/size J:148086
Hdac11tm1.2Mrl/Hdac11tm1.2Mrl
(involves: C57BL/6NTac) 		increased tumor growth/size J:222335
Hic1tm1Sbb/Hic1+
(involves: 129S4/SvJae * C57BL/6) 		increased metastatic potential J:81448
Hif1atm3Rsjo/Hif1atm3Rsjo
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		decreased tumor growth/size J:94773
Hip1tm4Tsr/Hip1+
Runx1tm3Dow/Runx1+
Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA) 		abnormal tumor morphology J:151974
Hmgn1tm1Mbus/Hmgn1tm1Mbus
(involves: 129X1/SvJ) 		increased metastatic potential J:100773
Hpcal1em1Ylzg/Hpcal1em1Ylzg
(C57BL/6J-Hpcal1em1Ylzg) 		abnormal tumor morphology J:331711
Hprt1tm1(Rcan1)Zyga/Hprt1+
(B6.129P2-Hprt1tm1(Rcan1)Zyga) 		decreased tumor growth/size J:150286
Hrhr/Hrhr
Ptger2tm1Brey/Ptger2tm1Brey
(involves: 129S6/SvEvTac * C57BL/6 * SKH1) 		abnormal tumor morphology J:117581
increased tumor growth/size J:117581
Htatip2tm1Hx/Htatip2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased metastatic potential J:87066
Hunktm1Lach/Hunk+
Tg(MMTV-Myc)#Led/0
(involves: 129P2/OlaHsd * C57BL/6J * CD-1) 		decreased metastatic potential J:153075
Hunktm1Lach/Hunktm1Lach
Tg(MMTV-Myc)#Led/0
(involves: 129P2/OlaHsd * C57BL/6J * CD-1) 		decreased metastatic potential J:153075
Icam1tm1Bay/Icam1tm1Bay
(B6.129S7-Icam1tm1Bay) 		increased tumor growth/size J:108135
Icam1tm1Bay/Icam1tm1Bay
Selltm1Tft/Selltm1Tft
(B6.129-Selltm1Tft Icam1tm1Bay) 		increased tumor growth/size J:108135
Id1tm1Zhu/Id1+
(involves: 129S1/Sv * 129S4/SvJaeSor) 		decreased metastatic potential J:86480
decreased tumor growth/size J:86480
tumor regression J:86480
Id1tm1Zhu/Id1+
Id3tm1Zhu/Id3tm1Zhu
(involves: 129S1/Sv * 129S4/SvJaeSor) 		abnormal tumor vascularization J:86480
decreased metastatic potential J:86480
decreased tumor growth/size J:86480
tumor regression J:86480
Idh2tm1Jwpk/Idh2tm1Jwpk
(involves: 129S4/SvJae * C57BL/6) 		abnormal tumor pathology J:210036
abnormal tumor vascularization J:210036
decreased tumor growth/size J:210036
Ifnar1tm1Agt/Ifnar1tm1Agt
(B6.129S2-Ifnar1tm1Agt) 		increased tumor growth/size J:118750
Ifnb1tm1Acgp/Ifnb1tm1Acgp
(involves: 129P2/OlaHsd) 		increased tumor growth/size J:86527
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * C57BL/6) 		increased metastatic potential J:152785
Ifngtm1Ts/Ifngtm1Ts
(C.129S7(B6)-Ifngtm1Ts/J) 		abnormal tumor pathology J:115144
Ifngtm1Ts/Ifngtm1Ts
Prf1tm1Sdz/Prf1tm1Sdz
(C.Cg-Prf1tm1Sdz Ifngtm1Ts) 		abnormal tumor morphology J:77491
Ifngr1tm1.1Rost/Ifngr1tm1.1Rost
(involves: BALB/cJ * C57BL/6) 		decreased metastatic potential J:152785
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd) 		abnormal tumor vascularization J:63089
Ifngr1tm1Agt/Ifngr1tm1Agt
(B6.129S7-Ifngr1tm1Agt/J) 		increased metastatic potential J:152785
Igf1tm1Dlr/Igf1tm1Dlr
Tg(Alb1-cre)1Dlr/0
(involves: 129/Sv * C57BL/6J * FVB/N) 		decreased tumor growth/size J:155733
Ightm1(Myc)Janz/Igh+
(involves: 129X1/SvJ * C57BL/6) 		abnormal tumor morphology J:160845
Ightm1(Myc)Janz/Igh+
Tg(Emu-FGFR3)A5Wmk/0
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		abnormal tumor morphology J:160845
Ightm1(Myc)Janz/Igh+
Tg(Emu-FGFR3)D3Wmk/0
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		abnormal tumor morphology J:160845
Igs2tm1(CAG-Met)Zsu/Igs2+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129 * C57BL/6 * DBA/2 * FVB/N) 		increased metastatic potential J:268934
Il1atm1Yiw/Il1atm1Yiw
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal tumor vascularization J:82394
decreased metastatic potential J:82394
Il1btm1Lvp/Il1btm1Lvp
(involves: 129S7/SvEvBrd) 		abnormal tumor vascularization J:82394
decreased metastatic potential J:59893, J:82394
decreased tumor growth/size J:59893, J:82394
Il5tm1Ktk/Il5tm1Ktk
(B6.129S4-Il5tm1Ktk) 		increased metastatic potential J:180790
Il5ratm1Ktk/Il5ratm1Ktk
(involves: 129P2/OlaHsd) 		increased metastatic potential J:180790
Il6ratm1.2Jcbr/Il6ratm1.2Jcbr
(involves: C57BL/6) 		decreased tumor growth/size J:202764
Il12rb2tm1Jm/Il12rb2tm1Jm
(B6;129S1-Il12rb2tm1Jm/J) 		abnormal tumor morphology J:120061
abnormal tumor vascularization J:120061
decreased tumor growth/size J:120061
Il22ra2tm2Vlcg/Il22ra2tm2Vlcg
(B6.Cg-Il22ra2tm2Vlcg) 		increased tumor growth/size J:189217
Immp2lTg(HLA-A/H2-D)2Enge/0
Tg(Mt1-RET)304Ina/0
(involves: BALB/c * C57BL/6 * CBA/Ca) 		increased metastatic potential J:130879
Inpp5jtm1.1Cmit/Inpp5jtm1.1Cmit
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6) 		abnormal tumor pathology J:224914
decreased metastatic potential J:224914
increased tumor growth/size J:224914
Iqgap1tm1Aber/Iqgap1tm1Aber
Iqgap2tm1Vs/Iqgap2tm1Vs
(involves: 129S4/SvJae) 		decreased tumor growth/size J:132670
Itga6tm2Egl/Itga6tm2Egl
Tg(Tie1-cre)9Ref/0
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal tumor vascularization J:156496
increased tumor growth/size J:156496
Itgaltm1Wpfl/Itgaltm1Wpfl
(involves: 129) 		increased metastatic potential J:37160
Itgb1tm1Ref/Itgb1tm1Ref
Tg(Ins2-cre)1Heed/?
Tg(RIP1-Tag)2Dh/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * CBA * DBA/2J) 		decreased metastatic potential J:122649
Itgb1tm1Ref/Itgb1tm1Ref
Tg(RIP1-Tag)2Dh/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J) 		abnormal tumor morphology J:122649
Itgb3tm1Hyn/Itgb3tm1.1Wlbcr
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		abnormal tumor pathology J:224675
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas * C57BL/6) 		abnormal tumor vascularization J:73752
increased tumor growth/size J:73752
Itgb3tm1Hyn/Itgb3tm1Hyn
Itgb5tm1Des/Itgb5tm1Des
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		abnormal tumor vascularization J:73752
increased tumor growth/size J:73752
Itgb3bptm1.1Tfw/Itgb3bptm1.1Tfw
(involves: C57BL/6J) 		abnormal tumor pathology J:271187
tumor regression J:271187
Jam3tm1.1Chav/Jam3tm1.1Chav
Tg(Tal1-cre/ERT)1Jrg/?
(involves: 129 * C57BL/6) 		decreased metastatic potential J:173391
Jam3tm1.1Chav/Jam3tm1.2Chav
Tg(Cdh5-cre)7Mlia/?
(involves: 129 * C57BL/6 * FVB/N) 		decreased metastatic potential J:173391
Jam3tm1.2Chav/Jam3tm1.2Chav
(B6.129-Jam3tm1.2Chav) 		decreased metastatic potential J:173391
Jcadtm1Kih/Jcadtm1Kih
(involves: C57BL/6) 		abnormal tumor vascularization J:247469
decreased tumor growth/size J:247469
Kars1Gt(AJ0130)Wtsi/Kars1+
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * FVB/N) 		decreased metastatic potential J:264950
Kif15em1Lium/Kif15em1Lium
(C57BL/6-Kif15em1Lium) 		decreased tumor growth/size J:336767
Kittm4.1Bsm/Kit+
(involves: 129S1/Sv * C57BL/6J * FVB/N) 		decreased tumor growth/size J:188434
Kittm5.1Bsm/Kit+
(involves: 129S1/Sv * C57BL/6J * FVB/N) 		increased tumor growth/size J:188434
Klf10tm1Wkle/Klf10tm1Wkle
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased tumor growth/size J:182595
Klhl22em1Cya/Klhl22em1Cya
(C57BL/6N-Klhl22em1Cya/Cya) 		abnormal tumor pathology J:297538
increased tumor growth/size J:297538
Krastm1Bbd/Kras+
Trp53tm1Brd/Trp53+
Tg(Cela1-tTA)#Eps/?
Tg(tetO-cre)3Jig/?
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * FVB/N) 		increased metastatic potential J:119988
Krastm2Tyj/Kras+
Trp53tm1Glo/Trp53+
(involves: 129S2/SvPas * 129S7/SvEvBrd) 		abnormal tumor morphology J:129627
increased metastatic potential J:129627
Krastm3Tyj/Kras+
Mir21atm1.1Eno/Mir21atm1.1Eno
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6) 		decreased tumor growth/size J:164198
Krastm3Tyj/Kras+
Tg(CAG-Mir21,-EGFP)#Eno/0
(involves: 129S4/SvJae * C3H * C57BL/6) 		increased tumor growth/size J:164198
Krastm3Tyj/Krastm3Tyj
Mir301tm1Yoli/Mir301tm1Yoli
(involves: 129S4/SvJae * C57BL/6J) 		decreased tumor growth/size J:237900
Krastm4Tyj/Kras+
(involves: 129S4/SvJae) 		abnormal tumor morphology J:147590
decreased tumor growth/size J:147590
Krastm4Tyj/Kras+
Ptentm1Hwu/Pten+
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased metastatic potential J:184935
Krastm4Tyj/Kras+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae * C57BL/6J) 		increased metastatic potential J:96296
Krastm4Tyj/Kras+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased metastatic potential J:184935
Krastm4Tyj/Kras+
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(TPO-cre)1Shk/0
(129.Cg-Krastm4Tyj Tg(Tpo-cre)1Shk Ptentm2.1Ppp) 		increased metastatic potential J:147732
Krastm4Tyj/Kras+
Ptf1atm1.1(cre)Cvw/Ptf1a+
(B6.Cg-Krastm4Tyj Ptf1atm1.1(cre)Cvw) 		increased metastatic potential J:138959
Krastm4Tyj/Kras+
Ptf1atm1.1(cre)Cvw/Ptf1a+
Tg(MUC1)79.24Gend/0
(B6.Cg-Krastm4Tyj Ptf1atm1.1(cre)Cvw Tg(MUC1)79.24Gend) 		decreased metastatic potential J:138959
Krastm4Tyj/Kras+
Rab11fip1tm1.1Jicn/Rab11fip1tm1.1Jicn
Tg(Pdx1-cre)6Tuv/0
Trp53tm2.1Tyj/Trp53+
(involves: 129S4/SvJae * FVB/N) 		decreased metastatic potential J:244261
Krastm4Tyj/Kras+
Ralatm1.2Cjm/Ralatm1.2Cjm
Ralbtm1.1Cjm/Ralbtm1.2Cjm
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J) 		decreased tumor growth/size J:199742
Krastm4Tyj/Kras+
Rb1tm3Tyj/Rb1tm3Tyj
(involves: 129S4/SvJae) 		abnormal tumor morphology J:147590
Krastm4Tyj/Kras+
Rbl2tm2Tyj/Rbl2tm2Tyj
(involves: 129S4/SvJae) 		abnormal tumor morphology J:147590
increased tumor growth/size J:147590
Krastm4Tyj/Kras+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Tg(Krt1-15-cre/PGR*)22Cot/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL/J) 		increased metastatic potential J:203922
Krastm4Tyj/Kras+
Stk11tm1.1Rdp/Stk11tm1.1Rdp
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased metastatic potential J:124682
Krastm4Tyj/Kras+
Stk11tm1.1Rdp/Stk11tm1.2Rdp
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased metastatic potential J:124682
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N) 		increased metastatic potential J:108298
Krastm4Tyj/Kras+
Tgfbr2tm1.2Hlm/Tgfbr2+
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased metastatic potential J:116129
Krastm4Tyj/Kras+
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
(B6.129-Krastm4Tyj Tgfbr2tm1.2Hlm) 		increased metastatic potential J:177379
Krastm4Tyj/Kras+
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased metastatic potential J:116129
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		increased metastatic potential J:184949
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased metastatic potential J:108298
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased metastatic potential J:103407
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased metastatic potential J:125101
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB/N) 		increased metastatic potential J:124682
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		increased metastatic potential J:184949
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Tg(Scgb1a1-rtTA)1Jaw/0
(involves: 129S4/SvJae) 		abnormal tumor morphology J:154041
decreased tumor growth/size J:154041
Krastm4Tyj/Kras+
Trp53tm3Glo/Trp53+
Tg(KRT5-cre/PGR)1Der/?
(involves: 129/Sv * C57BL/6 * FVB * ICR) 		abnormal tumor morphology J:124222
increased metastatic potential J:124222
Krastm4Tyj/Krastm4Tyj
Mir182tm1.1Dgk/Mir182+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129/Sv * 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased metastatic potential J:217635
Krastm4Tyj/Krastm4Tyj
Mir182tm1.1Dgk/Mir182tm1.1Dgk
Trp53tm1Brn/Trp53tm1Brn
(involves: 129/Sv * 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased metastatic potential J:217635
Krastm5Tyj/Kras+
Trp53tm1.1Dgk/Trp53tm1.1Dgk
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		increased tumor growth/size J:180576
Krt14tm1(cre)Wbm/Krt14+
Pard3tm1Shoh/Pard3tm1Shoh
(either: FVB.129-Pard3tm1Shoh Krt14tm1(cre)Wbm or (involves: 129P2/OlaHsd * 129S4/SvJae)) 		decreased tumor growth/size J:192905
increased metastatic potential J:192905
increased tumor growth/size J:192905
Lag3tm1Doi/Lag3tm1Doi
(involves: 129S2/SvPas * C57BL/6) 		decreased tumor growth/size J:269578
Lats1tm1Noj/Lats1tm1Noj
(involves: 129S2/SvPas * C57BL/6) 		abnormal tumor morphology J:200232
Laynem1Romd/Laynem1Romd
Tg(Cd8a-cre,-GFP)1Yzo/0
(involves: C57BL/6) 		increased tumor growth/size J:302853
Laynem2Romd/Laynem2Romd
(C57BL/6-Laynem2Romd) 		increased tumor growth/size J:302853
Ldhaa-m1Neu/Ldhaa-m1Neu
Tg(IGL-MYC)3Hm/0
(involves: 101/El * C3H/El * C57BL/6N) 		increased tumor growth/size J:183477
Lepob/Lepob
(B6.Cg-Lepob/J) 		increased metastatic potential J:117826
Leprdb/Leprdb
(B6.Cg-Dock7m +/+ Leprdb/J) 		increased metastatic potential J:117826
Lig4tm1Pmc/Lig4tm1Pmc
Trp53tm1Tyj/Trp53+
Xrcc2tm2Pmc/Xrcc2tm2Pmc
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL) 		abnormal tumor morphology J:144617
Loxl2tm1.2Acan/Loxl2tm1.2Acan
(Not Specified) 		abnormal tumor pathology J:220689
decreased tumor growth/size J:220689
Lrg1tm1.1Tnaka/Lrg1tm1.1Tnaka
(involves: C57BL/6J * CBA) 		increased tumor growth/size J:263152
Ltsd1C57BL/10J/Ltsd1C57BL/10J
Ltsd2C57BL/10J/Ltsd2C57BL/10J
(involves: C57BL/10 * O20/A) 		abnormal tumor morphology J:81057
Ltsd1C57BL/10J/Ltsd1O20/A
Ltsd5C57BL/10J/Ltsd5O20/A
(involves: C57BL/10 * O20/A) 		abnormal tumor morphology J:81057
Ltsd1O20/A/Ltsd1O20/A
Ltsd7O20/A/Ltsd7O20/A
(involves: C57BL/10 * O20/A) 		abnormal tumor morphology J:81057
Ltsd3C57BL/10J/Ltsd3C57BL/10J
Ltsd4C57BL/10J/Ltsd4C57BL/10J
(involves: C57BL/10 * O20/A) 		abnormal tumor morphology J:81057
Ltsd3O20/A/Ltsd3O20/A
Ltsd6O20/A/Ltsd6O20/A
(involves: C57BL/10 * O20/A) 		abnormal tumor morphology J:81057
Ltsd8O20/A/Ltsd8O20/A
(involves: C57BL/10 * O20/A) 		abnormal tumor morphology J:81057
Lyg1tm1(KOMP)Vlcg/Lyg1tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		increased tumor growth/size J:256594
Lystbg-2J/Lystbg-2J
(C3.Cg-Lystbg-2J/J) 		abnormal metastatic potential J:33522
decreased metastatic potential J:33522
Lyz2tm1(cre)Ifo/0
Nup85tm1.1Yter/Nup85tm1.1Yter
(involves: 129P2/OlaHsd * C57BL/6) 		decreased tumor growth/size J:292726
Map3k1tm1Glj/Map3k1tm1Glj
Tg(MMTV-PyVT)634Mul/0
(involves: 129S/SvEv * FVB/N) 		abnormal tumor morphology J:112298
decreased metastatic potential J:112298
Map3k8tm1.1Gkl/Map3k8tm1.1Gkl
Tg(Col6a1-cre)1Gkl/0
(involves: C57BL/6 * CBA * FVB/N) 		increased tumor growth/size J:193546
Map3k8tm1.2Gkl/Map3k8tm1.2Gkl
(involves: 129 * C57BL/6J * FVB/N) 		increased tumor growth/size J:193546
Mbd3tm2Bh/Mbd3tm2Bh
Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased tumor growth/size J:167984
Mcm3tm1.1Geno/Mcm3+
(involves: 129S2/SvPas * C57BL/6) 		increased metastatic potential J:227638
Mcm3tm1.2Geno/Mcm3+
(involves: 129S2/SvPas * C57BL/6) 		increased metastatic potential J:227638
Men1tm1.1Ctre/Men1+
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J * FVB/N) 		increased metastatic potential J:133299
Mfge8tm1Mcu/Mfge8tm1Mcu
Tg(RIP1-Tag)2Dh/?
(involves: 129X1/SvJ * C57BL/6J * C57BL/6NCr * DBA/2J) 		abnormal tumor morphology J:123138
decreased metastatic potential J:123138
decreased tumor growth/size J:123138
Mgat5tm1Jwd/Mgat5tm1Jwd
(involves: 129S1/Sv * 129X1/SvJ) 		decreased metastatic potential J:60960
decreased tumor growth/size J:60960
Mir21atm1Yoli/Mir21atm1Yoli
(involves: 129S6/SvEvTac * C57BL/6N) 		abnormal tumor pathology J:173464
Mir31em1Nju/Mir31em1Nju
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6J * FVB/N) 		decreased metastatic potential J:271420
decreased tumor growth/size J:271420
Mir122tm1.1Kgh/Mir122tm1.1Kgh
(involves: 129S1/Sv * 129X1/SvJ) 		increased tumor growth/size J:190067
Mki67em1Dfis/Mki67+
(involves: C57BL/6J) 		increased tumor growth/size J:304800
Mmp1atm1Otin/Mmp1atm1Otin
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal tumor morphology J:198586
decreased tumor growth/size J:198586
Mmp2tm1Ito/Mmp2tm1Ito
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased tumor growth/size J:46091
Mmp9tm1Itoh/Mmp9tm1Itoh
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased metastatic potential J:55823
Mmp9tm1Tvu/Mmp9tm1Tvu
(B6.129S6-Mmp9tm1Tvu) 		abnormal tumor morphology J:105098
Mmp9tm1Tvu/Mmp9tm1Tvu
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6 * FVB/N) 		abnormal tumor morphology J:140033
decreased metastatic potential J:140033
decreased tumor growth/size J:140033
Mmp9tm1Tvu/Mmp9tm1Tvu
Tg(MMTV-PyVT)634Mul/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		abnormal tumor morphology J:140033
decreased metastatic potential J:140033
decreased tumor growth/size J:140033
Mmp11tm1Mrio/Mmp11tm1Mrio
Tg(MMTV-vHaras)SH1Led/Tg(MMTV-vHaras)SH1Led
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6J * CD-1 * FVB) 		decreased tumor growth/size J:86074
increased metastatic potential J:86074
Mmrn2tm1Monm/Mmrn2tm1Monm
(involves: C57BL/6NCrl) 		abnormal tumor vascularization J:298039
Mmtp1I/LnJ/Mmtp1I/LnJ
Tg(MMTV-PyVT)634Mul/0
(involves: FVB/NJ * FVB/N-Tg(MMTV-PyVT)634Mul/J * I/LnJ) 		decreased tumor growth/size J:97671
Mmtp2NZB/BlNJ/Mmtp2NZB/BlNJ
Tg(MMTV-PyVT)634Mul/0
(involves: FVB/NJ * FVB/N-Tg(MMTV-PyVT)634Mul/J * I/LnJ) 		decreased tumor growth/size J:97671
Mmtp3NZB/BlNJ/Mmtp3NZB/BlNJ
Tg(MMTV-PyVT)634Mul/0
(involves: FVB/NJ * FVB/N-Tg(MMTV-PyVT)634Mul/J * I/LnJ) 		decreased tumor growth/size J:97671
Msh2tm1Rak/Msh2tm2.1Rak
Tg(Vil1-cre)20Syr/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * DBA/2 * SJL) 		abnormal tumor morphology J:161577
Msh2tm1Whl/Msh2tm1Whl
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal tumor morphology J:79016
Msh2tm1Whl/Msh2tm1Whl
Rb1tm1Brd/Rb1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		abnormal tumor morphology J:79016
Msh2tm2.1Rak/Msh2tm3.1Rak
Tg(Vil1-cre)20Syr/0
(involves: 129/Sv * C57BL/6 * DBA/2 * SJL) 		abnormal tumor morphology J:161577
Msi2Gt(Ayu21-T2)Imeg/Msi2Gt(Ayu21-T2)Imeg
(involves: C57BL/6 * CBA/JNCrlj) 		decreased tumor growth/size J:162770
Msmbtm1Xuan/Msmbtm1Xuan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * CD-1)) 		increased metastatic potential J:96884
Mtbptm1Glo/Mtbp+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6J) 		increased metastatic potential J:135509
MtdhGt(XB780)Byg/MtdhGt(XB780)Byg
Tg(MMTV-PyVT)634Mul/0
(FVB.Cg-MtdhGt(XB780)Byg Tg(MMTV-PyVT)634Mul) 		abnormal tumor pathology J:214244
decreased metastatic potential J:214244
MtdhGt(XB780)Byg/MtdhGt(XB780)Byg
Tg(MMTVneu)202Mul/0
(FVB.Cg-MtdhGt(XB780)Byg Tg(MMTVneu)202Mul) 		decreased metastatic potential J:214244
Mtes1NZB/BlNJ/Mtes1NZB/BlNJ
Tg(MMTV-PyVT)634Mul/0
(involves: FVB/NJ * FVB/N-Tg(MMTV-PyVT)634Mul/J * I/LnJ) 		decreased tumor growth/size J:97671
Muc1tm1Gend/Muc1tm1Gend
(B6.129P2-Muc1tm1Gend) 		decreased tumor growth/size J:30128
Muc1tm1Gend/Muc1tm1Gend
Tg(Wnt1)1Hev/?
(involves: FVB) 		decreased tumor growth/size J:82470
Myct1em1Choi/Myct1em1Choi
(involves: C57BL/6) 		abnormal tumor vascularization J:303692
decreased tumor growth/size J:303692
Myct1em1Choi/Myct1em1Choi
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * FVB/N) 		abnormal tumor vascularization J:303692
Nbeal2tm1a(EUCOMM)Wtsi/Nbeal2tm1a(EUCOMM)Wtsi
(C57BL/6N-Nbeal2tm1a(EUCOMM)Wtsi/Wtsi) 		decreased metastatic potential J:220801
Ncoa3tm1Jxu/Ncoa3tm1Jxu
Tg(MMTV-vHaras)SH1Led/0
(involves: 129S6/SvEvTac * C57BL/6J * CD-1) 		decreased metastatic potential J:88789
decreased tumor growth/size J:88789
Ncstntm1.1Akli/Ncstntm1.1Akli
Tet2tm1.1Iaai/Tet2tm1.1Iaai
Tg(VAV1-cre)1Graf/0
(involves: 129S/SvEv * C57BL/6) 		abnormal tumor pathology J:196407
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB/N) 		tumor regression J:223417
Nell1tm1Kuv/Nell1tm1Kuv
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(BGLAP-cre)1Clem/0
(involves: 129 * FVB/NJ) 		abnormal tumor morphology J:326989
abnormal tumor vascular morphology J:326989
Nf1tm1Tyj/Nf1+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased metastatic potential J:228258
Nf2tm1Gth/Nf2+
(involves: 129P2/OlaHsd * FVB/N) 		osseous metaplasia J:63264
Nf2tm1Gth/Nf2tm2Gth
Tg(Mpz-cre)#Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		osseous metaplasia J:63264
Nf2tm2Gth/Nf2tm2Gth
Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		osseous metaplasia J:92413
Nf2tm2Gth/Nf2tm2Gth
Tg(Mpz-cre)3Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		osseous metaplasia J:63264
Nf2tm2Gth/Nf2tm2Gth
Tg(Mpz-cre)#Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		osseous metaplasia J:63264
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brd/Trp53+
Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N) 		osseous metaplasia J:92413
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brd/Trp53tm1Brd
Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N) 		osseous metaplasia J:92413
Nmitm1.1Geno/Nmitm1.1Geno
Tg(KRT14-cre)1Amc/0
(B6.Cg-Nmitm1.1Geno Tg(KRT14-cre)1Amc) 		increased metastatic potential J:261035
Nmitm1.1Geno/Nmitm1.1Geno
Tg(KRT14-cre)1Amc/0
Tg(MMTVneu)202Mul/0
(involves: 129S/SvEv * C57BL/6 * CBA * FVB/N) 		increased metastatic potential J:261035
Nmral1Gt(S8-10A1)Sor/Nmral1Gt(S8-10A1)Sor
Tg(MMTV-PyVT)634Mul/0
(B6.Cg-Nmral1Gt(S8-10A1)Sor Tg(MMTV-PyVT)634Mul) 		decreased tumor growth/size J:282813
Nos2tm1Lau/Nos2tm1Lau
Tg(MMTV-PyVT)634Mul/0
(B6.Cg-Nos2tm1Lau Tg(MMTV-PyVT)634Mul) 		abnormal tumor morphology J:121391
Nos2tm1Lau/Nos2tm1Lau
Tg(MMTV-PyVT)634Mul/0
(FVB.Cg-Nos2tm1Lau Tg(MMTV-PyVT)634Mul) 		increased tumor growth/size J:121391
Npm1tm1Ppp/Npm1+
Tg(IghMyc)22Bri/0
(involves: 129S1/Sv * C57BL/6 * SJL) 		abnormal tumor morphology J:101494
Npr1tm1.1Kkan/Npr1tm1.1Kkan
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * SJL) 		increased metastatic potential J:220676
Nr4a1tm1Jmi/Nr4a1tm1Jmi
(involves: 129S2/SvPas * C57BL/6) 		increased tumor growth/size J:239509
Nrp1tm1.1Izac/Nrp1tm1.1Izac
(involves: 129S2/SvPas * C57BL/6) 		decreased tumor growth/size J:208348
Nufip1em1Cya/Nufip1em1Cya
S100a4em1(cre)Zhyg/S100a4+
(involves: C57BL/6J) 		decreased tumor growth/size J:330821
Nup85tm1.1Yter/Nup85tm1.1Yter
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA) 		decreased tumor growth/size J:292726
Palb2tm1.1Dli/Palb2tm1.1Dli
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * CBA) 		abnormal tumor morphology J:197442
Paqr3tm1Ychn/Paqr3tm1Ychn
(involves: 129 * C57BL/6J) 		increased tumor growth/size J:139058
Pdcd1tm1.1Liux/Pdcd1tm1.1Liux
(involves: C57BL/6) 		decreased tumor growth/size J:190150
Pdcd1tm1.1Liux/Pdcd1tm1.1Liux
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * FVB/N) 		decreased tumor growth/size J:190150
Pdcd1lg2tm1Dmp/Pdcd1lg2tm1Dmp
(C.129-Pdcd1lg2tm1Dmp) 		increased tumor growth/size J:99212
Peak1tm1.2Itl/Peak1tm1.2Itl
(involves: C57BL/6NTac * FVB/N) 		abnormal tumor vascularization J:278882
Pgftm1Pec/Pgftm1Pec
(either: (involves: 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * Swiss)) 		decreased tumor growth/size J:77481
Pgftm1Pec/Pgftm1Pec
(involves: 129) 		decreased tumor growth/size J:77481
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi
Tg(MMTVneu)202Mul/0
(involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6J * FVB/N) 		decreased tumor growth/size J:152332
Plautm1Mlg/Plautm1Mlg
(B6.Cg-Plautm1Mlg) 		abnormal tumor morphology J:65383
decreased metastatic potential J:65383
decreased tumor growth/size J:65383
Plcl1tm1.1Matk/Plcl1tm1.1Matk
(FVB.Cg-Plcl1tm1.1Matk) 		increased tumor growth/size J:207384
Pld1tm1.1Mafr/Pld1tm1.1Mafr
(B6.Cg-Pld1tm1.1Mafr) 		abnormal tumor vascularization J:193451
decreased metastatic potential J:193451
decreased tumor growth/size J:193451
Pldmq1FVB/NJ/?
(involves: FVB/NJ * M16i) 		increased metastatic potential J:136011
Pldmq2FVB/NJ/?
(involves: FVB/NJ * M16i) 		increased metastatic potential J:136011
Pldmq2M16i/?
(involves: FVB/NJ * M16i) 		increased metastatic potential J:136011
Pldmq3FVB/NJ/?
(involves: FVB/NJ * M16i) 		increased metastatic potential J:136011
Plgtm1Jld/Plgtm1Jld
(B6.129P2-Plgtm1Jld) 		decreased tumor growth/size J:44314
Plgtm1Jld/Plgtm1Jld
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * Black Swiss * FVB/N) 		decreased metastatic potential J:48285
Plk3tm1Dai/Plk3tm1Dai
(involves: 129S4/SvJae * C57BL/6) 		abnormal tumor morphology J:136425
increased tumor growth/size J:136425
Postntm1Kudo/Postntm1Kudo
(B6.Cg-Postntm1Kudo) 		increased tumor growth/size J:131295
Ppargc1atm1.1Amos/Ppargc1atm1.1Amos
(involves: C57BL/6JOlaHsd) 		increased tumor growth/size J:171361
Prdx1tm1Rave/Prdx1+
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal tumor morphology J:84677
Prf1tm1Sdz/Prf1tm1Sdz
(C.B6-Prf1tm1Sdz) 		abnormal tumor morphology J:77491
Prf1tm1Tsc/Prf1tm1Tsc
(129X1.129S2-Prf1tm1Tsc) 		increased tumor growth/size J:126114
Prkar1atm1.2Lsk/Prkar1atm1.2Lsk
Ptentm1.1Mwst/Ptentm1.1Mwst
Tg(TPO-cre)1Shk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/NCr) 		increased metastatic potential J:225245
Ptch1tm1Hahn/Ptch1tm1Hahn
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		decreased tumor growth/size J:158915
Ptch1tm1Yy/Ptch1+
Trp53tm1Brd/Trp53+
Tg(BGLAP-cre)1Clem/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/NJ) 		increased metastatic potential J:214349
Ptentm1.1Hwu/Pten+
(involves: 129S4/SvJae * BALB/c) 		abnormal metastatic potential J:110567
Ptentm1.1Mro/Pten+
(Not Specified) 		increased metastatic potential J:236514
Ptentm1.1Mro/Pten+
Sdhbtm1.2Ics/Sdhb+
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		increased metastatic potential J:236514
Ptentm1Hwu/Pten+
Tg(ARR2/Pbsn-FGF8)3Prb/0
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2) 		increased metastatic potential J:106650
Ptentm1Hwu/Ptentm1Hwu
Amhr2tm3(cre)Bhr/Amhr2+
(involves: 129S4/SvJae * 129S7/SvEvBrd) 		increased metastatic potential J:142150
Ptentm1Hwu/Ptentm1Hwu
Tg(Fabp1-cre)1Jig/0
(involves: 129S4/SvJae * FVB/N) 		increased metastatic potential J:106662
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased metastatic potential J:268934
Ptentm1Hwu/Ptentm1Hwu
Trp53tm2Tyj/Trp53+
Amhr2tm3(cre)Bhr/Amhr2+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd) 		increased metastatic potential J:222579
Ptentm1Rdp/Ptentm1Rdp
Smad4tm1Rdp/Smad4tm1Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129 * C57BL/6 * DBA/2) 		increased metastatic potential J:186105
Ptentm1Rdp/Ptentm1Rdp
Terttm1Rdp/Terttm1Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		decreased tumor growth/size J:186105
Ptentm1Rdp/Ptentm1Rdp
Terttm3Rdp/Terttm3Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased metastatic potential J:186105
Ptentm1Rps/Pten+
Tg(Wnt1)1Hev/0
(involves: 129S1/Sv * C57BL/6 * FVB/N * SJL) 		increased metastatic potential J:67497
Ptentm2.1Ppp/Ptentm2.1Ppp
Trp53tm1Brn/Trp53tm1Brn
Tg(TPO-cre)1Shk/0
(129.Cg-Tg(TPO-cre)1Shk Trp53tm1Brn Ptentm2.1Ppp) 		increased metastatic potential J:211100
Ptentm2Mak/Ptentm2Mak
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * DBA) 		increased metastatic potential J:90905
Ptentm2Mak/Ptentm2Mak
Tg(KLK3-cre)13Saa/0
(involves: 129P2/OlaHsd * C57BL/6) 		increased metastatic potential J:214242
Ptger1tm1Sna/Ptger1tm1Sna
(involves: 129P2/OlaHsd * C57BL/6Cr) 		decreased tumor growth/size J:95533
Ptger2tm1Brey/Ptger2tm1Brey
(involves: 129S6/SvEvTac) 		decreased tumor growth/size J:116015
Ptk2tm1Gwm/Ptk2tm1Gwm
Tg(KRT14-cre/ERT2)1Ipc/0
(involves: 129P2/OlaHsd * FVB) 		decreased tumor growth/size J:94680
Ptk2tm3.1Guan/Ptk2tm3.1Guan
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		abnormal tumor morphology J:195658
decreased metastatic potential J:195658
decreased tumor growth/size J:195658
Ptp4a3tm1.1Geh/Ptp4a3tm1.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased tumor growth/size J:194458
Ptprz1tm1Schl/Ptprz1tm1Schl
Trp53tm1Tyj/Trp53+
(involves: 129 * 129S2/SvPas * C57BL/6J) 		abnormal tumor pathology J:243104
Puf60tm1.1Kmtsu/Puf60+
Trp53tm1Sia/Trp53tm1Sia
(involves: C57BL/6NCrlj * C57BL/6NCrSlc * CBA/JNCrlj) 		increased metastatic potential J:233347
Qpctltm1.1Gne/Qpctltm1.1Gne
(C57BL/6N-Qpctltm1.1Gne) 		decreased tumor growth/size J:324112
Ralgdstm1Cjm/Ralgdstm1Cjm
(involves: 129X1/SvJ * MF1) 		decreased tumor growth/size J:96936
Rasal2Gt(463C12)Cmhd/Rasal2+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S * 129X1/SvJ * C57BL/6 * C57BL/6NCrl) 		increased metastatic potential J:202603
Rasal2Gt(463C12)Cmhd/Rasal2Gt(463C12)Cmhd
Tg(MMTVneu)202Mul/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl * FVB/N) 		increased metastatic potential J:202603
Rasal2Gt(463C12)Cmhd/Rasal2Gt(463C12)Cmhd
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S * 129X1/SvJ * C57BL/6 * C57BL/6NCrl) 		increased metastatic potential J:202603
Rb1tm1Brd/Rb1+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased metastatic potential J:17434
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * C57BL/6J) 		increased metastatic potential J:133299
Rb1tm1Tyj/Rb1+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		abnormal tumor morphology J:19542
Rb1tm2Brn/Rb1+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd) 		abnormal tumor pathology J:86077
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brd/Trp53+
Tg(Rbp3-cre)1Brn/0
(involves: 129 * 129S7/SvEvBrd * C57BL/6 * FVB/N) 		abnormal tumor morphology J:77982
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd) 		abnormal tumor pathology J:86077
increased metastatic potential J:84345
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)105Ayn/0
(FVB.Cg-Trp53tm1Brn Rb1tm2Brn Tg(MMTV-cre)105Ayn) 		increased tumor growth/size J:165292
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(Ren-cre)#Kwg/0
(involves: 129 * 129P2/OlaHsd) 		increased metastatic potential J:216559
Rb1tm3Tyj/Rb1+
Trp53tm1Brn/Trp53+
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * CD-1 * FVB/N) 		increased metastatic potential J:136693
Rb1tm3Tyj/Rb1+
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * CD-1 * FVB/N) 		increased metastatic potential J:136693
Rb1tm3Tyj/Rb1tm3Tyj
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
Tg(tetO-RNAi:Trp53)ASlowe/0
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		increased metastatic potential J:199542
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53+
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * CD-1 * FVB/N) 		increased metastatic potential J:136693
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * CD-1 * FVB/N) 		increased metastatic potential J:318035
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CD-1) 		increased metastatic potential J:199542
Rbpjtm1Hon/Rbpjtm1Hon
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129P2/OlaHsd * C57BL/10 * CBA/Ca) 		decreased tumor growth/size J:162770
Rcan1tm1Fmc/Rcan1+
Ts(1716)65Dn/0
(involves: 129S4/SvJae * C3H/HeSn * C57BL/6 * C57BL/6Ei * DBA/2J) 		decreased tumor growth/size J:150286
Rgs5tm1.1Rgan/Rgs5tm1.1Rgan
Tg(RIP1-Tag)5Dh/0
(C3.Cg-Rgs5tm1.1Rgan Tg(RIP1-Tag)5Dh) 		abnormal tumor morphology J:136259
increased tumor growth/size J:136259
Rhoctm1Mak/Rhoctm1Mak
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * FVB/N) 		decreased metastatic potential J:100482
Rhojtm1.1Auem/Rhojtm1.1Auem
Tg(Cdh5-cre/ERT2)1Rha/0
(involves: C57BL/6 * CBA/JNCrlj) 		abnormal tumor morphology J:208154
abnormal tumor vascularization J:208154
decreased tumor growth/size J:208154
Rhojtm1.2Auem/Rhojtm1.2Auem
(B6.Cg-Rhojtm1.2Auem) 		abnormal tumor morphology J:208154
abnormal tumor vascularization J:208154
decreased metastatic potential J:208154
decreased tumor growth/size J:208154
Rhojtm1.2Auem/Rhojtm1.2Auem
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * CBA/JNCrlj * FVB/N) 		abnormal tumor vascularization J:208154
decreased metastatic potential J:208154
decreased tumor growth/size J:208154
Rnf19btm1Jkorn/Rnf19btm1Jkorn
(B6.129S-Rnf19btm1Jkorn) 		increased metastatic potential J:157393
increased tumor growth/size J:157393
Rpl27aSfa/Rpl27a+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J) 		increased metastatic potential J:174216
Rr39em1Ched/Rr39em1Ched
(C57BL/6-Rr39em1Ched) 		increased tumor growth/size J:239509
Rr149356tm1Che/Rr149356tm1Che
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		decreased metastatic potential J:106246
RrasGt(OST24882)Lex/RrasGt(OST24882)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal tumor vascularization J:104130
Rrastm1Itl/Rras+
(involves: 129S6/SvEvTac * C57BL/6) 		increased tumor growth/size J:181730
Rrastm1Itl/Rrastm1Itl
(involves: 129S6/SvEvTac * C57BL/6) 		increased tumor growth/size J:181730
Runx1tm1(RUNX1)Gcg/Runx1tm1(RUNX1)Gcg
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		increased metastatic potential J:106800
S1pr2tm1Ytak/S1pr2tm1Ytak
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal tumor morphology J:168060
abnormal tumor vascularization J:168060
increased tumor growth/size J:168060
Selltm1Tft/Selltm1Tft
(B6.129P2-Selltm1Tft) 		increased tumor growth/size J:108135
Selltm2Hyn/Selltm2Hyn
(involves: 129S2/SvPas * C57BL/6) 		decreased metastatic potential J:106671
Setd4tm1c(KOMP)Wtsi/Setd4tm1c(KOMP)Wtsi
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6N) 		abnormal tumor pathology J:297725
decreased tumor growth/size J:297725
increased metastatic potential J:297725
Setd4tm1c(KOMP)Wtsi/Setd4tm1c(KOMP)Wtsi
Trp53tm1Brn/Trp53tm1Brn
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6N) 		decreased metastatic potential J:297725
increased tumor growth/size J:297725
Sf1Gt(pU17)1Teya/Sf1+
(involves: C57BL/6 * CBA) 		abnormal tumor morphology J:141491
Shc1tm5Paw/Shc1+
Tg(MMTV-PyVT)634Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		decreased metastatic potential J:133325
Shc1tm5Paw/Shc1tm5Paw
Tg(MMTV-PyVT)634Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		decreased metastatic potential J:133325
Shc1tm6Paw/Shc1+
Tg(MMTV-PyVT)634Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		decreased metastatic potential J:133325
Shc1tm6Paw/Shc1tm6Paw
Tg(MMTV-PyVT)634Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		decreased metastatic potential J:133325
Shc1tm7Paw/Shc1+
Tg(MMTV-PyVT)634Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		decreased metastatic potential J:133325
Shmt1Gt(AD0236)Wtsi/Shmt1Gt(AD0236)Wtsi
Tg(IGL-MYC)3Hm/0
(B6.Cg-Shmt1Gt(AD0236)Wtsi Tg(IGL-MYC)3Hm) 		increased tumor growth/size J:183477
Sirt1tm1.1Cxd/Sirt1+
Trp53tm1Brd/Trp53+
(either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB/N) or (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB/N)) 		abnormal tumor morphology J:140089
Skiltm1.1Kluo/Skiltm1.1Kluo
(B6.129P2-Skiltm1.1Kluo) 		decreased tumor growth/size J:154718
Slc3a2tm1.1Merl/Slc3a2+
Tg(Vil1-cre)997Gum/0
(B6.Cg-Slc3a2tm1.1Merl Tg(Vil1-cre)997Gum) 		decreased tumor growth/size J:173946
Slc6a14tm1Gana/Slc6a14tm1Gana
Tg(MMTV-PyVT)634Mul/0
(Not Specified) 		decreased metastatic potential J:226105
decreased tumor growth/size J:226105
Slc6a14tm1Gana/Slc6a14tm1Gana
Tg(MMTVneu)202Mul/0
(involves: FVB/N) 		decreased tumor growth/size J:226105
Sluc1O20/A/Sluc1O20/A
Sluc20O20/A/Sluc20O20/A
(involves: C57BL/10 * O20/A) 		increased tumor growth/size J:71973
Sluc10B10.O20/Dem/Sluc10B10.O20/Dem
Sluc25B10.O20/Dem/Sluc25B10.O20/Dem
(involves: B10.O20/Dem * O20/A) 		decreased tumor growth/size J:71973
Sluc10B10.O20/Dem/Sluc10B10.O20/Dem
Sluc25B10.O20/Dem/Sluc25O20/A
(involves: B10.O20/Dem * O20/A) 		decreased tumor growth/size J:71973
Sluc10B10.O20/Dem/Sluc10B10.O20/Dem
Sluc26O20/A/Sluc26O20/A
(involves: B10.O20/Dem * O20/A) 		increased tumor growth/size J:71973
Sluc10O20/A/Sluc10O20/A
Sluc25B10.O20/Dem/Sluc25B10.O20/Dem
(involves: B10.O20/Dem * O20/A) 		decreased tumor growth/size J:71973
Sluc12B10.O20/Dem/Sluc12B10.O20/Dem
Sluc22O20/A/Sluc22O20/A
(involves: C57BL/10 * O20/A) 		decreased tumor growth/size J:71973
Sluc12O20/A/Sluc12O20/A
Sluc5B10.O20/Dem/Sluc5B10.O20/Dem
(involves: C57BL/10 * O20/A) 		increased tumor growth/size J:71973
Sluc15B10.O20/Dem/Sluc15B10.O20/Dem
Sluc23O20/A/Sluc23O20/A
(involves: C57BL/10 * O20/A) 		decreased tumor growth/size J:71973
Sluc16B10.O20/Dem/Sluc16O20/A
Sluc5B10.O20/Dem/Sluc5B10.O20/Dem
(involves: B10.O20/Dem * O20/A) 		decreased tumor growth/size J:71973
Sluc17B10.O20/Dem/Sluc17B10.O20/Dem
Sluc20O20/A/Sluc20O20/A
(involves: C57BL/10 * O20/A) 		decreased tumor growth/size J:71973
Sluc19B10.O20/Dem/Sluc19B10.O20/Dem
Sluc27O20/A/Sluc27O20/A
(involves: C57BL/10 * O20/A) 		increased tumor growth/size J:71973
Sluc21B10.O20/Dem/Sluc21B10.O20/Dem
Sluc28O20/A/Sluc28O20/A
(involves: C57BL/10 * O20/A) 		decreased tumor growth/size J:71973
Sluc21O20/A/Sluc21O20/A
Sluc28B10.O20/Dem/Sluc28B10.O20/Dem
(involves: C57BL/10 * O20/A) 		increased tumor growth/size J:71973
Sluc23B10.O20/Dem/Sluc23O20/A
Sluc30O20/A/Sluc30O20/A
(involves: B10.O20/Dem * O20/A) 		increased tumor growth/size J:71973
Sluc24O20/A/Sluc24O20/A
Sluc5O20/A/Sluc5O20/A
(involves: C57BL/10 * O20/A) 		decreased tumor growth/size J:71973
Sluc25B10.O20/Dem/Sluc25B10.O20/Dem
Sluc5B10.O20/Dem/Sluc5B10.O20/Dem
(involves: B10.O20/Dem * O20/A) 		decreased tumor growth/size J:71973
Sluc25B10.O20/Dem/Sluc25B10.O20/Dem
Sluc5B10.O20/Dem/Sluc5O20/A
(involves: B10.O20/Dem * O20/A) 		decreased tumor growth/size J:71973
Sluc25B10.O20/Dem/Sluc25B10.O20/Dem
Sluc9O20/A/Sluc9O20/A
(involves: B10.O20/Dem * O20/A) 		decreased tumor growth/size J:71973
Sluc25B10.O20/Dem/Sluc25O20/A
Sluc5B10.O20/Dem/Sluc5B10.O20/Dem
(involves: B10.O20/Dem * O20/A) 		decreased tumor growth/size J:71973
Sluc26O20/A/Sluc26O20/A
Sluc5B10.O20/Dem/Sluc5B10.O20/Dem
(involves: B10.O20/Dem * O20/A) 		decreased tumor growth/size J:71973
Sluc29B10.O20/Dem/Sluc29B10.O20/Dem
Sluc9B10.O20/Dem/Sluc9B10.O20/Dem
(involves: B10.O20/Dem * O20/A) 		increased tumor growth/size J:71973
Smad3tm1Par/Smad3tm1Par
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		increased metastatic potential J:49839
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)7Mul/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * FVB/N) 		increased metastatic potential J:212549
Sparctm1Hwe/Sparctm1Hwe
(involves: 129S/SvEv * C57BL/6J) 		increased tumor growth/size J:81896
Srctm1Mul/Srctm1Mul
Tg(MMTV-PyVT)#Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		decreased tumor growth/size J:181822
Stab2tm1Ami/Stab2tm1Ami
(B6.Cg-Stab2tm1Ami) 		decreased metastatic potential J:182239
Stag1Gt(P099A04)Wrst/Stag1+
(involves: 129S2/SvPas) 		decreased tumor growth/size J:184720
Stard13tm1a(KOMP)Wtsi/Stard13tm1a(KOMP)Wtsi
(C57BL/6-Stard13tm1a(KOMP)Wtsi) 		abnormal tumor vascularization J:168264
increased tumor growth/size J:168264
Stat1tm1Rds/Stat1tm1Rds
(C3.129-Stat1tm1Rds) 		tumor regression J:108303
Stat3tm4Vpo/Stat3tm4Vpo
Tg(MMTV-Erbb2)1Pv/0
(involves: 129P2/OlaHsd * BALB/cAn * C57BL/6 * CD-1 * DBA) 		increased metastatic potential J:157976
increased tumor growth/size J:157976
Stat6tm1Gru/Stat6tm1Gru
(C.129S2-Stat6tm1Gru) 		decreased metastatic potential J:65894
Stk11tm1.1Rdp/Stk11tm1.1Rdp
Tg(Sprr2f-cre)1Dcas/0
(involves: 129S6/SvEvTac * FVB/N) 		increased metastatic potential J:158190
Tbx21tm1Glm/Tbx21tm1Glm
Tg(TRAMP)8247Ng/0
(involves: 129S6/SvEvTac * C57BL/6) 		increased metastatic potential J:88093
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
Tg(Pklr-Myc)73Ak/0
(B6.Cg-Tcra-Jtm1Tgi Tg(Pklr-Myc)73Ak) 		increased metastatic potential J:184496
Tg(Amy1TAg)501Knw/?
(C57BL/6-Tg(Amy1TAg)501Knw) 		increased metastatic potential J:90730
Tg(Bglap2-TAg)1Rkho/0
(FVB/N-Tg(Bglap2-TAg)1Rkho) 		increased metastatic potential J:165282
Tg(CAG-Alk*F1174L,-luc)60Jhsc/0
Tg(Dbh-icre)1Gsc/0
(involves: C57BL/6 * FVB/N) 		increased metastatic potential J:186696
Tg(CAG-Alk*F1174L,-luc)60Jhsc/0
Thtm1(cre)Te/Th+
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		increased metastatic potential J:186696
Tg(CAG-Bgeo,-tTA,-EGFP)2A11Kuw/0
Tg(Pdx1-cre)6Tuv/0
Tg(tetO-MYC)36Bop/0
(involves: 129P2/OlaHsd * FVB/N) 		increased metastatic potential J:197052
Tg(CAG-lacZ,-SV40)#Bcv/0
(involves: FVB/N) 		abnormal tumor morphology J:158388
increased metastatic potential J:158388
Tg(CD2-Fos)#Liux/0
(Not Specified) 		increased tumor growth/size J:190150
Tg(Cela1-luc,Cela1-TAg)#Nzh/0
(involves: FVB/N) 		increased metastatic potential J:207960
Tg(CMV-tTA)3Bjd/0
Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL) 		increased metastatic potential J:94953
Tg(Dct-Birc5)21Gros/0
Tg(Mt1-Hgf)19Lmb/0
(involves: C57BL/6 * CBA * FVB/N) 		increased metastatic potential J:122181
Tg(Ela1-Myc)158Bri/0
(involves: C57BL/6 * SJL) 		increased metastatic potential J:76992
Tg(Ela1-Myc)159Bri/0
(involves: C57BL/6 * SJL) 		increased metastatic potential J:76992
Tg(Ela1-Myc)160Bri/0
(involves: C57BL/6 * SJL) 		increased metastatic potential J:76992
Tg(Ela1-TAg*)79Mjt/0
(involves: C57BL/6 * DBA/2) 		increased metastatic potential J:78026
Tg(Gcg-TAg)25Ddr/?
(involves: CD-1) 		increased metastatic potential J:91490, J:101537
Tg(HRAS)2Jic/?
(involves: BALB/c * C57BL/6) 		abnormal tumor morphology J:64968
Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL) 		increased metastatic potential J:121564
Tg(KRT5-Akt1*)Jmpa/0
(involves: C57BL/6 * DBA/2 * DBA/2J * FVB/N) 		abnormal tumor morphology J:144831
Tg(KRT14-cre)8Brn/0
Tg(KRT5-Akt1*)Jmpa/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * DBA/2J * FVB/N) 		abnormal tumor morphology J:144831
Tg(KRT14-Snai1)1Efu/0
(involves: CD-1) 		increased metastatic potential J:229072
Tg(KRT19-TAg)7Eps/0
(involves: FVB/N) 		increased metastatic potential J:64395
Tg(LYZ-rtTA2S*M2,tetO-ELAVL1)632Dkon/0
(B6.Cg-Tg(LYZ-rtTA2S*M2,tetO-ELAVL1)632Dkon) 		decreased tumor growth/size J:184388
Tg(MMTV-ERBB2)5Erick/?
(FVB/N-Tg(MMTV-ERBB2)5Erick) 		increased metastatic potential J:90202
Tg(MMTV-KRAS*G12V)3025Mrl/0
(involves: C57BL/6 * FVB * SJL) 		increased metastatic potential J:77272
Tg(MMTV-LPAR1)#Gbm/Tg(MMTV-LPAR1)#Gbm
(FVB/N-Tg(MMTV-LPAR1)#Gbm) 		increased metastatic potential J:149661
Tg(MMTV-LPAR2)#Gbm/Tg(MMTV-LPAR2)#Gbm
(FVB/N-Tg(MMTV-LPAR2)#Gbm) 		increased metastatic potential J:149661
Tg(MMTV-LPAR3)#Gbm/Tg(MMTV-LPAR3)#Gbm
(FVB/N-Tg(MMTV-LPAR3)#Gbm) 		increased metastatic potential J:149661
Tg(MMTV-Myc)WT13Jrn/0
(involves: FVB/N) 		increased metastatic potential J:153233
Tg(MMTV-Myc)WT21Jrn/0
(involves: FVB/N) 		increased metastatic potential J:153233
Tg(MMTV-NCOA3)#Mybr/0
(FVB/N-Tg(MMTV-NCOA3)#Mybr) 		increased metastatic potential J:93548
Tg(MMTV-Notch4)3Rnc/0
(involves: FVB/N) 		increased metastatic potential J:11644
Tg(MMTV-PyVT)634Mul/0
(FVB/N-Tg(MMTV-PyVT)634Mul/Nci) 		increased metastatic potential J:46460, J:48285
Tg(MMTV-PyVT)634Mul/0
(multiple strains) 		decreased metastatic potential J:48854
increased metastatic potential J:48854
Tg(MMTV-PyVT)634Mul/0
(FVB/N-Tg(MMTV-PyVT)634Mul/J) 		abnormal tumor morphology J:140033
increased tumor growth/size J:140033
Tg(MMTV-PyVT)#Mul/0
(B6.FVB-Tg(MMTV-PyVT)#Mul) 		increased metastatic potential J:147923
Tg(MMTV-rtTA)1Lach/0
Tg(TetO-Erbb2)1Lach/0
(involves: FVB) 		increased metastatic potential J:81083
Tg(MMTV-rtTA)1Lach/0
Tg(tetO-ERBB2)#Jjz/0
(involves: FVB/N) 		increased metastatic potential J:231766
Tg(MMTV-rtTA)1Lach/0
Tg(tetO-PyVT,-cre)1Mul/0
(FVB/N-Tg(MMTV-rtTA)1Lach Tg(tetO-PyVT,-cre)#Mul) 		increased metastatic potential J:231983
Tg(MMTV-vHaras)SH1Led/Tg(MMTV-vHaras)SH1Led
(involves: 129X1/SvJ * C57BL/6J * CD-1 * FVB) 		increased metastatic potential J:86074
Tg(MMTVneu)202Mul/0
(FVB/N-Tg(MMTVneu)202Mul) 		increased metastatic potential J:56332
Tg(Msmb-TAg)183-2Xuan/0
(involves: C57BL/6 * CBA) 		increased metastatic potential J:80313
Tg(Mt1-Hgf)19Lmb/0
(involves: FVB/N) 		increased metastatic potential J:50947
Tg(Mt1-RET)304Ina/0
(involves: BALB/c * C57BL/6) 		increased metastatic potential J:155735
Tg(OMP-SV40T)13Bse/0
(involves: C57BL/6 * SJL) 		increased metastatic potential J:54269
Tg(Pbsn-Ar*E231G)7353Ng/0
(involves: FVB/N) 		increased metastatic potential J:96117
Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp/0
(FVB-Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp) 		increased metastatic potential J:130340
Tg(Pbsn-Hpn,-GFP)DVv/0
Tg(Pbsn-Tag)12T7fRjm/0
(involves: C57BL/6J * CBA * CD-1) 		increased metastatic potential J:92562
Tg(Pbsn-IGF1*)5305Ng/0
Tg(TRAMP)8247Ng/0
(involves: C57BL/6 * FVB/N) 		abnormal metastatic potential J:144539
Tg(Pbsn-Tag)12T10Rjm/0
(involves: CD-1) 		increased metastatic potential J:68483
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*T790M*L858R)19Kkw/0
(involves: 129 * C57BL/6 * FVB/N) 		increased metastatic potential J:122849
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-MYC)36Bop/0
(involves: 129 * C57BL/6) 		increased metastatic potential J:169920
Tg(SERPINC1-SV40)A1Pbr/0
(involves: C57BL/6 * DBA/2) 		increased metastatic potential J:101541
X/Tg(SERPINC1-SV40)BPbr
(involves: C57BL/6 * DBA/2) 		abnormal tumor vascularization J:84204
Tg(SFTPC-CCNE1)1Edm/?
(involves: FVB/N) 		increased metastatic potential J:122698
Tg(SFTPC-CCNE1*T62A*T380A)3Edm/?
(involves: FVB/N) 		increased metastatic potential J:122698
Tg(SFTPC-CCNE1*T62A*T380A)4Edm/?
(involves: FVB/N) 		increased metastatic potential J:122698
Tg(SFTPC-env)1Yhch/0
(FVB/N-Tg(SFTPC-env)1Yhch) 		increased metastatic potential J:247986
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-MYC)36Bop/0
(Not Specified) 		increased metastatic potential J:169920
Tg(Slc1a2-tTA)#Waw/0
Tg(tetO-MYCN,-luc)#Waw/0
(involves: FVB/NJ) 		increased metastatic potential J:160518
Tg(Slc1a2-tTA)#Waw/0
Tg(tetO-MYCN,-luc)#Waw/Tg(tetO-MYCN,-luc)#Waw
(involves: FVB/NJ) 		increased metastatic potential J:160518
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
Tg(tetO-RNAi:Trp53)ASlowe/0
(involves: C57BL/6 * CD-1) 		increased metastatic potential J:199542
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129 * 129P2/OlaHsd * C57BL/6J * CD-1 * FVB/N) 		increased metastatic potential J:136693
Tg(Tal1-cre/ERT)1Jrg/0
Tsc1tm1Djk/Tsc1tm1Djk
(involves: 129S4/SvJae * C57BL/6) 		increased metastatic potential J:231316
Tg(Tek-Npr1)#Kkan/0
(involves: C57BL/6) 		decreased metastatic potential J:220676
Tg(tetO-MYC)36aBop/0
Tg(Cebpb-tTA)5Bjd/0
(involves: FVB/N * NMRI) 		decreased tumor growth/size J:190067
Tg(TG-NRAS*Q61K)#Msnt/0
(Not Specified) 		increased metastatic potential J:210016
Tg(TG-RET/NCOA4)3209Rstn/0
(involves: C57BL/6) 		increased metastatic potential J:51366
Tg(TG-SV40)#Cled/0
(involves: C57BL/6J * DBA/2J) 		increased metastatic potential J:209788
Tg(TRAMP)8247Ng/0
Tmprss2tm1Psn/Tmprss2tm1Psn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased metastatic potential J:217920
increased tumor growth/size J:217920
Tg(TRAMP)8247Ng/0
Usp11tm1Tac/Y
(involves: 129 * C57BL/6) 		increased metastatic potential J:270214
increased tumor growth/size J:270214
Tg(UPII-SV40T)29Xrw/0
(involves: FVB/N) 		increased metastatic potential J:56305
Tg(Upk2-TAg)1Rkl/0
(involves: C57BL/6) 		abnormal metastatic potential J:173505
abnormal tumor vascularization J:173505
Tg(Vil1-PPARGC1A)#Amos/0
(involves: FVB/N) 		decreased tumor growth/size J:171361
Tg(Vil-SLC3A2)HEMerl/0
(involves: FVB/N) 		increased tumor growth/size J:173946
Tg(Wap-Hgf)402Mig/0
(involves: FVB/N) 		increased metastatic potential J:86776
X/Tg(Wap-HRAS)69Lln
(involves: C57BL/6 * SJL) 		abnormal metastatic potential J:46458
Tgfb1i1tm1.2Cet/Tgfb1i1tm1.2Cet
Tg(MMTV-PyVT)634Mul/0
(involves: 129S/SvEv * C57BL/6 * FVB/N) 		decreased metastatic potential J:241234
Tgm2tm1Gml/Tgm2tm1Gml
(involves: C57BL/6) 		increased tumor growth/size J:126131
Thbs1tm1Hyn/Thbs1tm1Hyn
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		abnormal tumor morphology J:72391
Ticam1tm1Tsse/Ticam1tm1Tsse
(B6.129-Ticam1tm1Tsse) 		increased tumor growth/size J:118750
TigarGt(EUCE0047g05)Hmgu/TigarGt(EUCE0047g05)Hmgu
Apctm1Tno/Apctm1Tno
Lgr5tm1(cre/ERT2)Cle/Lgr5+
(involves: 129P2/OlaHsd * 129S4/SvJae) 		decreased tumor growth/size J:198650
Tle5tm1.1Mmt/Tle5tm1.1Mmt
Apctm1Mmt/Apc+
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S2/SvPas * C57BL/6 * DBA * SJL) 		increased metastatic potential J:168065
Tmem219tm1(KOMP)Vlcg/Tmem219tm1(KOMP)Vlcg
(B6J.B6N-Tmem219tm1(KOMP)Vlcg) 		decreased metastatic potential J:236976
Tnfrsf1atm4.1(TNFRSF1A)Gkl/Tnfrsf1a+
(involves: 129P2/OlaHsd) 		tumor regression J:210950
Tnfrsf10btm1.1Cjk/Tnfrsf10btm1.1Cjk
(involves: 129P2/OlaHsd * BALB/c * NIH/OlaHsd) 		increased metastatic potential J:130806
Tnfsf10tm1Sdg/Tnfsf10tm1Sdg
(C.129-Tnfsf10tm1Sdg) 		increased tumor growth/size J:79085
Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		increased metastatic potential J:133892
Tpx2Gt(D028B03)Wrst/Tpx2+
(involves: 129S2/SvPas * C57BL/6J) 		increased metastatic potential J:184948
Trim11em1Bcgen/Trim11+
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6N * FVB/N) 		decreased tumor growth/size J:329445
Trim16tm1Gmma/Trim16+
Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2) 		increased metastatic potential J:290272
Trim16tm1Gmma/Trim16tm1Gmma
Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2) 		increased tumor growth/size J:290272
Trim27Gt(XP0484)Wtsi/Trim27Gt(XP0484)Wtsi
(B6.129P2-Trim27Gt(XP0484)Wtsi) 		decreased tumor growth/size J:189317
Trp53tm1Brd/Trp53tm1Brd
(NIHOla.129S7-Trp53tm1Brd) 		decreased tumor growth/size J:93298
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)#Mam/0
(involves: 129P2/OlaHsd * FVB) 		abnormal tumor morphology J:162126
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		increased metastatic potential J:199542
Trp53tm1Glo/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased metastatic potential J:61683
Trp53tm1Glo/Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal tumor morphology J:171821
Trp53tm1Glo/Trp53tm4Glo
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		abnormal tumor pathology J:171821
tumor regression J:171821
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		abnormal tumor morphology J:17728
Trp53tm1Tyj/Trp53+
Trp63tm1Fmc/Trp63+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased metastatic potential J:98958
Trp53tm1Tyj/Trp53+
Trp73tm1Fmc/Trp73+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased metastatic potential J:98958
Trp53tm1Tyj/Trp53+
Uimc1tm1.2Amj/Uimc1tm1.2Amj
(involves: 129S2/SvPas * BALB/cJ * C57BL/6) 		increased tumor growth/size J:191827
Trp53tm2.1Tyj/Trp53+
(involves: 129S4/SvJae) 		increased metastatic potential J:95316
Trp53tm3.1Glo/Trp53+
(B6.129S7-Trp53tm3.1Glo) 		increased metastatic potential J:95318
Trp53tm3.1Glo/Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal tumor morphology J:171821
Trp53tm3.1Glo/Trp53tm4Glo
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		abnormal tumor pathology J:171821
decreased tumor growth/size J:171821
Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae) 		increased metastatic potential J:95316
Trp53tm6Xu/Trp53tm6Xu
Tg(Lck-cre)1Cwi/0
(involves: 129S4/SvJae) 		increased metastatic potential J:157041
Trp63tm1Fmc/Trp63+
Trp73tm1Fmc/Trp73+
(involves: 129S4/SvJae * C57BL/6) 		increased metastatic potential J:98958
Ts(1716)65Dn/0
(B6EiC3Sn a/A-Ts(1716)65Dn/J) 		decreased tumor growth/size J:150286
Tsc1tm1Hin/Tsc1+
(involves: 129S4/SvJae * C57BL/6J) 		abnormal tumor morphology J:70463
Tsc2tm1.1Mjg/Tsc2tm1.1Mjg
Pgrtm2(cre)Lyd/Pgr+
(involves: 129S1/Sv * 129X1/SvJ) 		increased metastatic potential J:221228
Ube2otm1.1(KOMP)Mbp/Ube2o+
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * C57BL/6N * FVB/N) 		decreased tumor growth/size J:239679
Ube2otm1.1(KOMP)Mbp/Ube2o+
Tg(TRAMP)8247Ng/0
(involves: C57BL/6 * C57BL/6N * FVB/N) 		decreased tumor growth/size J:239679
Ube2otm1.1(KOMP)Mbp/Ube2otm1.1(KOMP)Mbp
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * C57BL/6N * FVB/N) 		decreased tumor growth/size J:239679
Ube2otm1.1(KOMP)Mbp/Ube2otm1.1(KOMP)Mbp
Tg(TRAMP)8247Ng/0
(involves: C57BL/6 * C57BL/6N * FVB/N) 		decreased metastatic potential J:239679
decreased tumor growth/size J:239679
Vegfatm2Gne/Vegfatm2Gne
Tg(Csf1r-cre/Esr1*)1Jwp/0
(involves: 129 * C57BL/6 * FVB/N) 		decreased metastatic potential J:186831
Vegfdtm1Hrl/Y
(B6.129S-Vegfdtm1Hrl) 		decreased metastatic potential J:153734
Wdfy4em1Jkln/Wdfy4em1Jkln
(C57BL/6J-Wdfy4em1Jkln) 		increased tumor growth/size J:326216
Xpatm1Tnka/Xpatm1Tnka
Tg(KRT14-Kitl)1Takk/?
(involves: C57BL/6 * CBA * SJL) 		increased metastatic potential J:100608
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
05/07/2024
MGI 6.23 		The Jackson Laboratory